{"subnetworks": [{"diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE", "CARDIAC ARRHYTHMIA", "EPILEPSY", "SEIZURES", "AMYOTROPHIC LATERAL SCLEROSIS", "UNIPOLAR DEPRESSION", "PROLONGED QT INTERVAL", "VENTRICULAR TACHYCARDIA", "VENTRICULAR FIBRILLATION", "ATRIAL FIBRILLATION"], "links": [{"source": "ENSG00000026559", "target": "ENSG00000053918"}, {"source": "ENSG00000026559", "target": "ENSG00000055118"}, {"source": "ENSG00000026559", "target": "ENSG00000075043"}, {"source": "ENSG00000026559", "target": "ENSG00000089558"}, {"source": "ENSG00000026559", "target": "ENSG00000104848"}, {"source": "ENSG00000026559", "target": "ENSG00000111262"}, {"source": "ENSG00000026559", "target": "ENSG00000116396"}, {"source": "ENSG00000026559", "target": "ENSG00000117013"}, {"source": "ENSG00000026559", "target": "ENSG00000124134"}, {"source": "ENSG00000026559", "target": "ENSG00000129159"}, {"source": "ENSG00000026559", "target": "ENSG00000130037"}, {"source": "ENSG00000026559", "target": "ENSG00000131398"}, {"source": "ENSG00000026559", "target": "ENSG00000135519"}, {"source": "ENSG00000026559", "target": "ENSG00000140015"}, {"source": "ENSG00000026559", "target": "ENSG00000143105"}, {"source": "ENSG00000026559", "target": "ENSG00000143473"}, {"source": "ENSG00000026559", "target": "ENSG00000151079"}, {"source": "ENSG00000026559", "target": "ENSG00000156486"}, {"source": "ENSG00000026559", "target": "ENSG00000158445"}, {"source": "ENSG00000026559", "target": "ENSG00000162975"}, {"source": "ENSG00000026559", "target": "ENSG00000164794"}, {"source": "ENSG00000026559", "target": "ENSG00000166006"}, {"source": "ENSG00000026559", "target": "ENSG00000168263"}, {"source": "ENSG00000026559", "target": "ENSG00000168418"}, {"source": "ENSG00000026559", "target": "ENSG00000170745"}, {"source": "ENSG00000026559", "target": "ENSG00000171126"}, {"source": "ENSG00000026559", "target": "ENSG00000171385"}, {"source": "ENSG00000026559", "target": "ENSG00000173826"}, {"source": "ENSG00000026559", "target": "ENSG00000177272"}, {"source": "ENSG00000026559", "target": "ENSG00000177301"}, {"source": "ENSG00000026559", "target": "ENSG00000178342"}, {"source": "ENSG00000026559", "target": "ENSG00000182255"}, {"source": "ENSG00000026559", "target": "ENSG00000182674"}, {"source": "ENSG00000026559", "target": "ENSG00000183960"}, {"source": "ENSG00000026559", "target": "ENSG00000184156"}, {"source": "ENSG00000026559", "target": "ENSG00000184408"}, {"source": "ENSG00000026559", "target": "ENSG00000184611"}, {"source": "ENSG00000026559", "target": "ENSG00000185760"}, {"source": "ENSG00000053918", "target": "ENSG00000055118"}, {"source": "ENSG00000053918", "target": "ENSG00000075043"}, {"source": "ENSG00000053918", "target": "ENSG00000089558"}, {"source": "ENSG00000053918", "target": "ENSG00000104848"}, {"source": "ENSG00000053918", "target": "ENSG00000111262"}, {"source": "ENSG00000053918", "target": "ENSG00000116396"}, {"source": "ENSG00000053918", "target": "ENSG00000117013"}, {"source": "ENSG00000053918", "target": "ENSG00000124134"}, {"source": "ENSG00000053918", "target": "ENSG00000129159"}, {"source": "ENSG00000053918", "target": "ENSG00000130037"}, {"source": "ENSG00000053918", "target": "ENSG00000131398"}, {"source": "ENSG00000053918", "target": "ENSG00000135519"}, {"source": "ENSG00000053918", "target": "ENSG00000140015"}, {"source": "ENSG00000053918", "target": "ENSG00000143105"}, {"source": "ENSG00000053918", "target": "ENSG00000143473"}, {"source": "ENSG00000053918", "target": "ENSG00000151079"}, {"source": "ENSG00000053918", "target": "ENSG00000156486"}, {"source": "ENSG00000053918", "target": "ENSG00000158445"}, {"source": "ENSG00000053918", "target": "ENSG00000162975"}, {"source": "ENSG00000053918", "target": "ENSG00000164794"}, {"source": "ENSG00000053918", "target": "ENSG00000166006"}, {"source": "ENSG00000053918", "target": "ENSG00000168263"}, {"source": "ENSG00000053918", "target": "ENSG00000168418"}, {"source": "ENSG00000053918", "target": "ENSG00000170745"}, {"source": "ENSG00000053918", "target": "ENSG00000171126"}, {"source": "ENSG00000053918", "target": "ENSG00000171385"}, {"source": "ENSG00000053918", "target": "ENSG00000173826"}, {"source": "ENSG00000053918", "target": "ENSG00000177272"}, {"source": "ENSG00000053918", "target": "ENSG00000177301"}, {"source": "ENSG00000053918", "target": "ENSG00000178342"}, {"source": "ENSG00000053918", "target": "ENSG00000182255"}, {"source": "ENSG00000053918", "target": "ENSG00000182674"}, {"source": "ENSG00000053918", "target": "ENSG00000183960"}, {"source": "ENSG00000053918", "target": "ENSG00000184156"}, {"source": "ENSG00000053918", "target": "ENSG00000184408"}, {"source": "ENSG00000053918", "target": "ENSG00000184611"}, {"source": "ENSG00000053918", "target": "ENSG00000185760"}, {"source": "ENSG00000055118", "target": "ENSG00000075043"}, {"source": "ENSG00000055118", "target": "ENSG00000089558"}, {"source": "ENSG00000055118", "target": "ENSG00000104848"}, {"source": "ENSG00000055118", "target": "ENSG00000111262"}, {"source": "ENSG00000055118", "target": "ENSG00000116396"}, {"source": "ENSG00000055118", "target": "ENSG00000117013"}, {"source": "ENSG00000055118", "target": "ENSG00000124134"}, {"source": "ENSG00000055118", "target": "ENSG00000129159"}, {"source": "ENSG00000055118", "target": "ENSG00000130037"}, {"source": "ENSG00000055118", "target": "ENSG00000131398"}, {"source": "ENSG00000055118", "target": "ENSG00000135519"}, {"source": "ENSG00000055118", "target": "ENSG00000140015"}, {"source": "ENSG00000055118", "target": "ENSG00000143105"}, {"source": "ENSG00000055118", "target": "ENSG00000143473"}, {"source": "ENSG00000055118", "target": "ENSG00000151079"}, {"source": "ENSG00000055118", "target": "ENSG00000156486"}, {"source": "ENSG00000055118", "target": "ENSG00000157554"}, {"source": "ENSG00000055118", "target": "ENSG00000158445"}, {"source": "ENSG00000055118", "target": "ENSG00000162975"}, {"source": "ENSG00000055118", "target": "ENSG00000164794"}, {"source": "ENSG00000055118", "target": "ENSG00000166006"}, {"source": "ENSG00000055118", "target": "ENSG00000168263"}, {"source": "ENSG00000055118", "target": "ENSG00000168418"}, {"source": "ENSG00000055118", "target": "ENSG00000170745"}, {"source": "ENSG00000055118", "target": "ENSG00000171126"}, {"source": "ENSG00000055118", "target": "ENSG00000171385"}, {"source": "ENSG00000055118", "target": "ENSG00000173826"}, {"source": "ENSG00000055118", "target": "ENSG00000177272"}, {"source": "ENSG00000055118", "target": "ENSG00000177301"}, {"source": "ENSG00000055118", "target": "ENSG00000178342"}, {"source": "ENSG00000055118", "target": "ENSG00000182255"}, {"source": "ENSG00000055118", "target": "ENSG00000182674"}, {"source": "ENSG00000055118", "target": "ENSG00000183960"}, {"source": "ENSG00000055118", "target": "ENSG00000184156"}, {"source": "ENSG00000055118", "target": "ENSG00000184408"}, {"source": "ENSG00000055118", "target": "ENSG00000184611"}, {"source": "ENSG00000055118", "target": "ENSG00000185760"}, {"source": "ENSG00000075043", "target": "ENSG00000089558"}, {"source": "ENSG00000075043", "target": "ENSG00000104848"}, {"source": "ENSG00000075043", "target": "ENSG00000111262"}, {"source": "ENSG00000075043", "target": "ENSG00000116396"}, {"source": "ENSG00000075043", "target": "ENSG00000117013"}, {"source": "ENSG00000075043", "target": "ENSG00000124134"}, {"source": "ENSG00000075043", "target": "ENSG00000129159"}, {"source": "ENSG00000075043", "target": "ENSG00000130037"}, {"source": "ENSG00000075043", "target": "ENSG00000131398"}, {"source": "ENSG00000075043", "target": "ENSG00000135519"}, {"source": "ENSG00000075043", "target": "ENSG00000140015"}, {"source": "ENSG00000075043", "target": "ENSG00000143105"}, {"source": "ENSG00000075043", "target": "ENSG00000143473"}, {"source": "ENSG00000075043", "target": "ENSG00000151079"}, {"source": "ENSG00000075043", "target": "ENSG00000156486"}, {"source": "ENSG00000075043", "target": "ENSG00000158445"}, {"source": "ENSG00000075043", "target": "ENSG00000162975"}, {"source": "ENSG00000075043", "target": "ENSG00000164794"}, {"source": "ENSG00000075043", "target": "ENSG00000166006"}, {"source": "ENSG00000075043", "target": "ENSG00000168263"}, {"source": "ENSG00000075043", "target": "ENSG00000168418"}, {"source": "ENSG00000075043", "target": "ENSG00000170745"}, {"source": "ENSG00000075043", "target": "ENSG00000171126"}, {"source": "ENSG00000075043", "target": "ENSG00000171385"}, {"source": "ENSG00000075043", "target": "ENSG00000173826"}, {"source": "ENSG00000075043", "target": "ENSG00000177272"}, {"source": "ENSG00000075043", "target": "ENSG00000177301"}, {"source": "ENSG00000075043", "target": "ENSG00000178342"}, {"source": "ENSG00000075043", "target": "ENSG00000182255"}, {"source": "ENSG00000075043", "target": "ENSG00000182674"}, {"source": "ENSG00000075043", "target": "ENSG00000183960"}, {"source": "ENSG00000075043", "target": "ENSG00000184156"}, {"source": "ENSG00000075043", "target": "ENSG00000184408"}, {"source": "ENSG00000075043", "target": "ENSG00000184611"}, {"source": "ENSG00000075043", "target": "ENSG00000185760"}, {"source": "ENSG00000089558", "target": "ENSG00000104848"}, {"source": "ENSG00000089558", "target": "ENSG00000111262"}, {"source": "ENSG00000089558", "target": "ENSG00000116396"}, {"source": "ENSG00000089558", "target": "ENSG00000117013"}, {"source": "ENSG00000089558", "target": "ENSG00000124134"}, {"source": "ENSG00000089558", "target": "ENSG00000129159"}, {"source": "ENSG00000089558", "target": "ENSG00000130037"}, {"source": "ENSG00000089558", "target": "ENSG00000131398"}, {"source": "ENSG00000089558", "target": "ENSG00000135519"}, {"source": "ENSG00000089558", "target": "ENSG00000140015"}, {"source": "ENSG00000089558", "target": "ENSG00000143105"}, {"source": "ENSG00000089558", "target": "ENSG00000143473"}, {"source": "ENSG00000089558", "target": "ENSG00000151079"}, {"source": "ENSG00000089558", "target": "ENSG00000156486"}, {"source": "ENSG00000089558", "target": "ENSG00000158445"}, {"source": "ENSG00000089558", "target": "ENSG00000162975"}, {"source": "ENSG00000089558", "target": "ENSG00000164794"}, {"source": "ENSG00000089558", "target": "ENSG00000166006"}, {"source": "ENSG00000089558", "target": "ENSG00000168263"}, {"source": "ENSG00000089558", "target": "ENSG00000168418"}, {"source": "ENSG00000089558", "target": "ENSG00000170745"}, {"source": "ENSG00000089558", "target": "ENSG00000171126"}, {"source": "ENSG00000089558", "target": "ENSG00000171385"}, {"source": "ENSG00000089558", "target": "ENSG00000173826"}, {"source": "ENSG00000089558", "target": "ENSG00000177272"}, {"source": "ENSG00000089558", "target": "ENSG00000177301"}, {"source": "ENSG00000089558", "target": "ENSG00000178342"}, {"source": "ENSG00000089558", "target": "ENSG00000182255"}, {"source": "ENSG00000089558", "target": "ENSG00000182674"}, {"source": "ENSG00000089558", "target": "ENSG00000183960"}, {"source": "ENSG00000089558", "target": "ENSG00000184156"}, {"source": "ENSG00000089558", "target": "ENSG00000184408"}, {"source": "ENSG00000089558", "target": "ENSG00000184611"}, {"source": "ENSG00000089558", "target": "ENSG00000185760"}, {"source": "ENSG00000102057", "target": "ENSG00000182132"}, {"source": "ENSG00000104848", "target": "ENSG00000111262"}, {"source": "ENSG00000104848", "target": "ENSG00000116396"}, {"source": "ENSG00000104848", "target": "ENSG00000117013"}, {"source": "ENSG00000104848", "target": "ENSG00000124134"}, {"source": "ENSG00000104848", "target": "ENSG00000129159"}, {"source": "ENSG00000104848", "target": "ENSG00000130037"}, {"source": "ENSG00000104848", "target": "ENSG00000131398"}, {"source": "ENSG00000104848", "target": "ENSG00000135519"}, {"source": "ENSG00000104848", "target": "ENSG00000140015"}, {"source": "ENSG00000104848", "target": "ENSG00000143105"}, {"source": "ENSG00000104848", "target": "ENSG00000143473"}, {"source": "ENSG00000104848", "target": "ENSG00000151079"}, {"source": "ENSG00000104848", "target": "ENSG00000156486"}, {"source": "ENSG00000104848", "target": "ENSG00000158445"}, {"source": "ENSG00000104848", "target": "ENSG00000162975"}, {"source": "ENSG00000104848", "target": "ENSG00000164794"}, {"source": "ENSG00000104848", "target": "ENSG00000166006"}, {"source": "ENSG00000104848", "target": "ENSG00000168263"}, {"source": "ENSG00000104848", "target": "ENSG00000168418"}, {"source": "ENSG00000104848", "target": "ENSG00000170745"}, {"source": "ENSG00000104848", "target": "ENSG00000171126"}, {"source": "ENSG00000104848", "target": "ENSG00000171385"}, {"source": "ENSG00000104848", "target": "ENSG00000173826"}, {"source": "ENSG00000104848", "target": "ENSG00000177272"}, {"source": "ENSG00000104848", "target": "ENSG00000177301"}, {"source": "ENSG00000104848", "target": "ENSG00000178342"}, {"source": "ENSG00000104848", "target": "ENSG00000182255"}, {"source": "ENSG00000104848", "target": "ENSG00000182674"}, {"source": "ENSG00000104848", "target": "ENSG00000183960"}, {"source": "ENSG00000104848", "target": "ENSG00000184156"}, {"source": "ENSG00000104848", "target": "ENSG00000184408"}, {"source": "ENSG00000104848", "target": "ENSG00000184611"}, {"source": "ENSG00000104848", "target": "ENSG00000185760"}, {"source": "ENSG00000111262", "target": "ENSG00000116396"}, {"source": "ENSG00000111262", "target": "ENSG00000117013"}, {"source": "ENSG00000111262", "target": "ENSG00000124134"}, {"source": "ENSG00000111262", "target": "ENSG00000129159"}, {"source": "ENSG00000111262", "target": "ENSG00000130037"}, {"source": "ENSG00000111262", "target": "ENSG00000131398"}, {"source": "ENSG00000111262", "target": "ENSG00000135519"}, {"source": "ENSG00000111262", "target": "ENSG00000140015"}, {"source": "ENSG00000111262", "target": "ENSG00000143105"}, {"source": "ENSG00000111262", "target": "ENSG00000143473"}, {"source": "ENSG00000111262", "target": "ENSG00000151079"}, {"source": "ENSG00000111262", "target": "ENSG00000156486"}, {"source": "ENSG00000111262", "target": "ENSG00000158445"}, {"source": "ENSG00000111262", "target": "ENSG00000162975"}, {"source": "ENSG00000111262", "target": "ENSG00000164794"}, {"source": "ENSG00000111262", "target": "ENSG00000166006"}, {"source": "ENSG00000111262", "target": "ENSG00000168263"}, {"source": "ENSG00000111262", "target": "ENSG00000168418"}, {"source": "ENSG00000111262", "target": "ENSG00000170745"}, {"source": "ENSG00000111262", "target": "ENSG00000171126"}, {"source": "ENSG00000111262", "target": "ENSG00000171385"}, {"source": "ENSG00000111262", "target": "ENSG00000173826"}, {"source": "ENSG00000111262", "target": "ENSG00000177272"}, {"source": "ENSG00000111262", "target": "ENSG00000177301"}, {"source": "ENSG00000111262", "target": "ENSG00000178342"}, {"source": "ENSG00000111262", "target": "ENSG00000182255"}, {"source": "ENSG00000111262", "target": "ENSG00000182674"}, {"source": "ENSG00000111262", "target": "ENSG00000183960"}, {"source": "ENSG00000111262", "target": "ENSG00000184156"}, {"source": "ENSG00000111262", "target": "ENSG00000184408"}, {"source": "ENSG00000111262", "target": "ENSG00000184611"}, {"source": "ENSG00000111262", "target": "ENSG00000185760"}, {"source": "ENSG00000116396", "target": "ENSG00000117013"}, {"source": "ENSG00000116396", "target": "ENSG00000124134"}, {"source": "ENSG00000116396", "target": "ENSG00000129159"}, {"source": "ENSG00000116396", "target": "ENSG00000130037"}, {"source": "ENSG00000116396", "target": "ENSG00000131398"}, {"source": "ENSG00000116396", "target": "ENSG00000135519"}, {"source": "ENSG00000116396", "target": "ENSG00000140015"}, {"source": "ENSG00000116396", "target": "ENSG00000143105"}, {"source": "ENSG00000116396", "target": "ENSG00000143473"}, {"source": "ENSG00000116396", "target": "ENSG00000151079"}, {"source": "ENSG00000116396", "target": "ENSG00000156486"}, {"source": "ENSG00000116396", "target": "ENSG00000158445"}, {"source": "ENSG00000116396", "target": "ENSG00000162975"}, {"source": "ENSG00000116396", "target": "ENSG00000164794"}, {"source": "ENSG00000116396", "target": "ENSG00000166006"}, {"source": "ENSG00000116396", "target": "ENSG00000168263"}, {"source": "ENSG00000116396", "target": "ENSG00000168418"}, {"source": "ENSG00000116396", "target": "ENSG00000170745"}, {"source": "ENSG00000116396", "target": "ENSG00000171126"}, {"source": "ENSG00000116396", "target": "ENSG00000171385"}, {"source": "ENSG00000116396", "target": "ENSG00000173826"}, {"source": "ENSG00000116396", "target": "ENSG00000177272"}, {"source": "ENSG00000116396", "target": "ENSG00000177301"}, {"source": "ENSG00000116396", "target": "ENSG00000178342"}, {"source": "ENSG00000116396", "target": "ENSG00000182255"}, {"source": "ENSG00000116396", "target": "ENSG00000182674"}, {"source": "ENSG00000116396", "target": "ENSG00000183960"}, {"source": "ENSG00000116396", "target": "ENSG00000184156"}, {"source": "ENSG00000116396", "target": "ENSG00000184408"}, {"source": "ENSG00000116396", "target": "ENSG00000184611"}, {"source": "ENSG00000116396", "target": "ENSG00000185760"}, {"source": "ENSG00000117013", "target": "ENSG00000124134"}, {"source": "ENSG00000117013", "target": "ENSG00000129159"}, {"source": "ENSG00000117013", "target": "ENSG00000130037"}, {"source": "ENSG00000117013", "target": "ENSG00000131398"}, {"source": "ENSG00000117013", "target": "ENSG00000135519"}, {"source": "ENSG00000117013", "target": "ENSG00000140015"}, {"source": "ENSG00000117013", "target": "ENSG00000143105"}, {"source": "ENSG00000117013", "target": "ENSG00000143473"}, {"source": "ENSG00000117013", "target": "ENSG00000151079"}, {"source": "ENSG00000117013", "target": "ENSG00000156486"}, {"source": "ENSG00000117013", "target": "ENSG00000158445"}, {"source": "ENSG00000117013", "target": "ENSG00000162975"}, {"source": "ENSG00000117013", "target": "ENSG00000164794"}, {"source": "ENSG00000117013", "target": "ENSG00000166006"}, {"source": "ENSG00000117013", "target": "ENSG00000168263"}, {"source": "ENSG00000117013", "target": "ENSG00000168418"}, {"source": "ENSG00000117013", "target": "ENSG00000170745"}, {"source": "ENSG00000117013", "target": "ENSG00000171126"}, {"source": "ENSG00000117013", "target": "ENSG00000171385"}, {"source": "ENSG00000117013", "target": "ENSG00000173826"}, {"source": "ENSG00000117013", "target": "ENSG00000177272"}, {"source": "ENSG00000117013", "target": "ENSG00000177301"}, {"source": "ENSG00000117013", "target": "ENSG00000178342"}, {"source": "ENSG00000117013", "target": "ENSG00000182255"}, {"source": "ENSG00000117013", "target": "ENSG00000182674"}, {"source": "ENSG00000117013", "target": "ENSG00000183960"}, {"source": "ENSG00000117013", "target": "ENSG00000184156"}, {"source": "ENSG00000117013", "target": "ENSG00000184408"}, {"source": "ENSG00000117013", "target": "ENSG00000184611"}, {"source": "ENSG00000117013", "target": "ENSG00000185760"}, {"source": "ENSG00000124134", "target": "ENSG00000129159"}, {"source": "ENSG00000124134", "target": "ENSG00000130037"}, {"source": "ENSG00000124134", "target": "ENSG00000131398"}, {"source": "ENSG00000124134", "target": "ENSG00000135519"}, {"source": "ENSG00000124134", "target": "ENSG00000140015"}, {"source": "ENSG00000124134", "target": "ENSG00000143105"}, {"source": "ENSG00000124134", "target": "ENSG00000143473"}, {"source": "ENSG00000124134", "target": "ENSG00000151079"}, {"source": "ENSG00000124134", "target": "ENSG00000156486"}, {"source": "ENSG00000124134", "target": "ENSG00000158445"}, {"source": "ENSG00000124134", "target": "ENSG00000162975"}, {"source": "ENSG00000124134", "target": "ENSG00000164794"}, {"source": "ENSG00000124134", "target": "ENSG00000166006"}, {"source": "ENSG00000124134", "target": "ENSG00000168263"}, {"source": "ENSG00000124134", "target": "ENSG00000168418"}, {"source": "ENSG00000124134", "target": "ENSG00000170745"}, {"source": "ENSG00000124134", "target": "ENSG00000171126"}, {"source": "ENSG00000124134", "target": "ENSG00000171385"}, {"source": "ENSG00000124134", "target": "ENSG00000173826"}, {"source": "ENSG00000124134", "target": "ENSG00000177272"}, {"source": "ENSG00000124134", "target": "ENSG00000177301"}, {"source": "ENSG00000124134", "target": "ENSG00000178342"}, {"source": "ENSG00000124134", "target": "ENSG00000182255"}, {"source": "ENSG00000124134", "target": "ENSG00000182674"}, {"source": "ENSG00000124134", "target": "ENSG00000183960"}, {"source": "ENSG00000124134", "target": "ENSG00000184156"}, {"source": "ENSG00000124134", "target": "ENSG00000184408"}, {"source": "ENSG00000124134", "target": "ENSG00000184611"}, {"source": "ENSG00000124134", "target": "ENSG00000185760"}, {"source": "ENSG00000129159", "target": "ENSG00000130037"}, {"source": "ENSG00000129159", "target": "ENSG00000131398"}, {"source": "ENSG00000129159", "target": "ENSG00000135519"}, {"source": "ENSG00000129159", "target": "ENSG00000140015"}, {"source": "ENSG00000129159", "target": "ENSG00000143105"}, {"source": "ENSG00000129159", "target": "ENSG00000143473"}, {"source": "ENSG00000129159", "target": "ENSG00000151079"}, {"source": "ENSG00000129159", "target": "ENSG00000156486"}, {"source": "ENSG00000129159", "target": "ENSG00000158445"}, {"source": "ENSG00000129159", "target": "ENSG00000162975"}, {"source": "ENSG00000129159", "target": "ENSG00000164794"}, {"source": "ENSG00000129159", "target": "ENSG00000166006"}, {"source": "ENSG00000129159", "target": "ENSG00000168263"}, {"source": "ENSG00000129159", "target": "ENSG00000168418"}, {"source": "ENSG00000129159", "target": "ENSG00000170745"}, {"source": "ENSG00000129159", "target": "ENSG00000171126"}, {"source": "ENSG00000129159", "target": "ENSG00000171385"}, {"source": "ENSG00000129159", "target": "ENSG00000173826"}, {"source": "ENSG00000129159", "target": "ENSG00000177272"}, {"source": "ENSG00000129159", "target": "ENSG00000177301"}, {"source": "ENSG00000129159", "target": "ENSG00000178342"}, {"source": "ENSG00000129159", "target": "ENSG00000182255"}, {"source": "ENSG00000129159", "target": "ENSG00000182674"}, {"source": "ENSG00000129159", "target": "ENSG00000183960"}, {"source": "ENSG00000129159", "target": "ENSG00000184156"}, {"source": "ENSG00000129159", "target": "ENSG00000184408"}, {"source": "ENSG00000129159", "target": "ENSG00000184611"}, {"source": "ENSG00000129159", "target": "ENSG00000185760"}, {"source": "ENSG00000130037", "target": "ENSG00000131398"}, {"source": "ENSG00000130037", "target": "ENSG00000135519"}, {"source": "ENSG00000130037", "target": "ENSG00000140015"}, {"source": "ENSG00000130037", "target": "ENSG00000143105"}, {"source": "ENSG00000130037", "target": "ENSG00000143473"}, {"source": "ENSG00000130037", "target": "ENSG00000151079"}, {"source": "ENSG00000130037", "target": "ENSG00000156486"}, {"source": "ENSG00000130037", "target": "ENSG00000158445"}, {"source": "ENSG00000130037", "target": "ENSG00000162975"}, {"source": "ENSG00000130037", "target": "ENSG00000164794"}, {"source": "ENSG00000130037", "target": "ENSG00000166006"}, {"source": "ENSG00000130037", "target": "ENSG00000168263"}, {"source": "ENSG00000130037", "target": "ENSG00000168418"}, {"source": "ENSG00000130037", "target": "ENSG00000170745"}, {"source": "ENSG00000130037", "target": "ENSG00000171126"}, {"source": "ENSG00000130037", "target": "ENSG00000171385"}, {"source": "ENSG00000130037", "target": "ENSG00000173826"}, {"source": "ENSG00000130037", "target": "ENSG00000177272"}, {"source": "ENSG00000130037", "target": "ENSG00000177301"}, {"source": "ENSG00000130037", "target": "ENSG00000178342"}, {"source": "ENSG00000130037", "target": "ENSG00000182255"}, {"source": "ENSG00000130037", "target": "ENSG00000182674"}, {"source": "ENSG00000130037", "target": "ENSG00000183960"}, {"source": "ENSG00000130037", "target": "ENSG00000184156"}, {"source": "ENSG00000130037", "target": "ENSG00000184408"}, {"source": "ENSG00000130037", "target": "ENSG00000184611"}, {"source": "ENSG00000130037", "target": "ENSG00000185760"}, {"source": "ENSG00000130226", "target": "ENSG00000184408"}, {"source": "ENSG00000131398", "target": "ENSG00000135519"}, {"source": "ENSG00000131398", "target": "ENSG00000140015"}, {"source": "ENSG00000131398", "target": "ENSG00000143105"}, {"source": "ENSG00000131398", "target": "ENSG00000143473"}, {"source": "ENSG00000131398", "target": "ENSG00000151079"}, {"source": "ENSG00000131398", "target": "ENSG00000156486"}, {"source": "ENSG00000131398", "target": "ENSG00000158445"}, {"source": "ENSG00000131398", "target": "ENSG00000162975"}, {"source": "ENSG00000131398", "target": "ENSG00000164794"}, {"source": "ENSG00000131398", "target": "ENSG00000166006"}, {"source": "ENSG00000131398", "target": "ENSG00000168263"}, {"source": "ENSG00000131398", "target": "ENSG00000168418"}, {"source": "ENSG00000131398", "target": "ENSG00000170745"}, {"source": "ENSG00000131398", "target": "ENSG00000171126"}, {"source": "ENSG00000131398", "target": "ENSG00000171385"}, {"source": "ENSG00000131398", "target": "ENSG00000173826"}, {"source": "ENSG00000131398", "target": "ENSG00000177272"}, {"source": "ENSG00000131398", "target": "ENSG00000177301"}, {"source": "ENSG00000131398", "target": "ENSG00000178342"}, {"source": "ENSG00000131398", "target": "ENSG00000182255"}, {"source": "ENSG00000131398", "target": "ENSG00000182674"}, {"source": "ENSG00000131398", "target": "ENSG00000183960"}, {"source": "ENSG00000131398", "target": "ENSG00000184156"}, {"source": "ENSG00000131398", "target": "ENSG00000184408"}, {"source": "ENSG00000131398", "target": "ENSG00000184611"}, {"source": "ENSG00000131398", "target": "ENSG00000185760"}, {"source": "ENSG00000135519", "target": "ENSG00000140015"}, {"source": "ENSG00000135519", "target": "ENSG00000143105"}, {"source": "ENSG00000135519", "target": "ENSG00000143473"}, {"source": "ENSG00000135519", "target": "ENSG00000151079"}, {"source": "ENSG00000135519", "target": "ENSG00000156486"}, {"source": "ENSG00000135519", "target": "ENSG00000158445"}, {"source": "ENSG00000135519", "target": "ENSG00000162975"}, {"source": "ENSG00000135519", "target": "ENSG00000164794"}, {"source": "ENSG00000135519", "target": "ENSG00000166006"}, {"source": "ENSG00000135519", "target": "ENSG00000168263"}, {"source": "ENSG00000135519", "target": "ENSG00000168418"}, {"source": "ENSG00000135519", "target": "ENSG00000170745"}, {"source": "ENSG00000135519", "target": "ENSG00000171126"}, {"source": "ENSG00000135519", "target": "ENSG00000171385"}, {"source": "ENSG00000135519", "target": "ENSG00000173826"}, {"source": "ENSG00000135519", "target": "ENSG00000177272"}, {"source": "ENSG00000135519", "target": "ENSG00000177301"}, {"source": "ENSG00000135519", "target": "ENSG00000178342"}, {"source": "ENSG00000135519", "target": "ENSG00000182255"}, {"source": "ENSG00000135519", "target": "ENSG00000182674"}, {"source": "ENSG00000135519", "target": "ENSG00000183960"}, {"source": "ENSG00000135519", "target": "ENSG00000184156"}, {"source": "ENSG00000135519", "target": "ENSG00000184408"}, {"source": "ENSG00000135519", "target": "ENSG00000184611"}, {"source": "ENSG00000135519", "target": "ENSG00000185760"}, {"source": "ENSG00000140015", "target": "ENSG00000143105"}, {"source": "ENSG00000140015", "target": "ENSG00000143473"}, {"source": "ENSG00000140015", "target": "ENSG00000151079"}, {"source": "ENSG00000140015", "target": "ENSG00000156486"}, {"source": "ENSG00000140015", "target": "ENSG00000158445"}, {"source": "ENSG00000140015", "target": "ENSG00000162975"}, {"source": "ENSG00000140015", "target": "ENSG00000164794"}, {"source": "ENSG00000140015", "target": "ENSG00000166006"}, {"source": "ENSG00000140015", "target": "ENSG00000168263"}, {"source": "ENSG00000140015", "target": "ENSG00000168418"}, {"source": "ENSG00000140015", "target": "ENSG00000170745"}, {"source": "ENSG00000140015", "target": "ENSG00000171126"}, {"source": "ENSG00000140015", "target": "ENSG00000171385"}, {"source": "ENSG00000140015", "target": "ENSG00000173826"}, {"source": "ENSG00000140015", "target": "ENSG00000177272"}, {"source": "ENSG00000140015", "target": "ENSG00000177301"}, {"source": "ENSG00000140015", "target": "ENSG00000178342"}, {"source": "ENSG00000140015", "target": "ENSG00000182255"}, {"source": "ENSG00000140015", "target": "ENSG00000182674"}, {"source": "ENSG00000140015", "target": "ENSG00000183960"}, {"source": "ENSG00000140015", "target": "ENSG00000184156"}, {"source": "ENSG00000140015", "target": "ENSG00000184408"}, {"source": "ENSG00000140015", "target": "ENSG00000184611"}, {"source": "ENSG00000140015", "target": "ENSG00000185760"}, {"source": "ENSG00000143105", "target": "ENSG00000143473"}, {"source": "ENSG00000143105", "target": "ENSG00000151079"}, {"source": "ENSG00000143105", "target": "ENSG00000156486"}, {"source": "ENSG00000143105", "target": "ENSG00000158445"}, {"source": "ENSG00000143105", "target": "ENSG00000162975"}, {"source": "ENSG00000143105", "target": "ENSG00000164794"}, {"source": "ENSG00000143105", "target": "ENSG00000166006"}, {"source": "ENSG00000143105", "target": "ENSG00000168263"}, {"source": "ENSG00000143105", "target": "ENSG00000168418"}, {"source": "ENSG00000143105", "target": "ENSG00000170745"}, {"source": "ENSG00000143105", "target": "ENSG00000171126"}, {"source": "ENSG00000143105", "target": "ENSG00000171385"}, {"source": "ENSG00000143105", "target": "ENSG00000173826"}, {"source": "ENSG00000143105", "target": "ENSG00000177272"}, {"source": "ENSG00000143105", "target": "ENSG00000177301"}, {"source": "ENSG00000143105", "target": "ENSG00000178342"}, {"source": "ENSG00000143105", "target": "ENSG00000182255"}, {"source": "ENSG00000143105", "target": "ENSG00000182674"}, {"source": "ENSG00000143105", "target": "ENSG00000183960"}, {"source": "ENSG00000143105", "target": "ENSG00000184156"}, {"source": "ENSG00000143105", "target": "ENSG00000184408"}, {"source": "ENSG00000143105", "target": "ENSG00000184611"}, {"source": "ENSG00000143105", "target": "ENSG00000185760"}, {"source": "ENSG00000143473", "target": "ENSG00000151079"}, {"source": "ENSG00000143473", "target": "ENSG00000156486"}, {"source": "ENSG00000143473", "target": "ENSG00000158445"}, {"source": "ENSG00000143473", "target": "ENSG00000162975"}, {"source": "ENSG00000143473", "target": "ENSG00000164794"}, {"source": "ENSG00000143473", "target": "ENSG00000166006"}, {"source": "ENSG00000143473", "target": "ENSG00000168263"}, {"source": "ENSG00000143473", "target": "ENSG00000168418"}, {"source": "ENSG00000143473", "target": "ENSG00000170745"}, {"source": "ENSG00000143473", "target": "ENSG00000171126"}, {"source": "ENSG00000143473", "target": "ENSG00000171385"}, {"source": "ENSG00000143473", "target": "ENSG00000173826"}, {"source": "ENSG00000143473", "target": "ENSG00000177272"}, {"source": "ENSG00000143473", "target": "ENSG00000177301"}, {"source": "ENSG00000143473", "target": "ENSG00000178342"}, {"source": "ENSG00000143473", "target": "ENSG00000182255"}, {"source": "ENSG00000143473", "target": "ENSG00000182674"}, {"source": "ENSG00000143473", "target": "ENSG00000183960"}, {"source": "ENSG00000143473", "target": "ENSG00000184156"}, {"source": "ENSG00000143473", "target": "ENSG00000184408"}, {"source": "ENSG00000143473", "target": "ENSG00000184611"}, {"source": "ENSG00000143473", "target": "ENSG00000185760"}, {"source": "ENSG00000151079", "target": "ENSG00000156486"}, {"source": "ENSG00000151079", "target": "ENSG00000158445"}, {"source": "ENSG00000151079", "target": "ENSG00000162975"}, {"source": "ENSG00000151079", "target": "ENSG00000164794"}, {"source": "ENSG00000151079", "target": "ENSG00000166006"}, {"source": "ENSG00000151079", "target": "ENSG00000168263"}, {"source": "ENSG00000151079", "target": "ENSG00000168418"}, {"source": "ENSG00000151079", "target": "ENSG00000170745"}, {"source": "ENSG00000151079", "target": "ENSG00000171126"}, {"source": "ENSG00000151079", "target": "ENSG00000171385"}, {"source": "ENSG00000151079", "target": "ENSG00000173826"}, {"source": "ENSG00000151079", "target": "ENSG00000177272"}, {"source": "ENSG00000151079", "target": "ENSG00000177301"}, {"source": "ENSG00000151079", "target": "ENSG00000178342"}, {"source": "ENSG00000151079", "target": "ENSG00000182255"}, {"source": "ENSG00000151079", "target": "ENSG00000182674"}, {"source": "ENSG00000151079", "target": "ENSG00000183960"}, {"source": "ENSG00000151079", "target": "ENSG00000184156"}, {"source": "ENSG00000151079", "target": "ENSG00000184408"}, {"source": "ENSG00000151079", "target": "ENSG00000184611"}, {"source": "ENSG00000151079", "target": "ENSG00000185760"}, {"source": "ENSG00000156486", "target": "ENSG00000158445"}, {"source": "ENSG00000156486", "target": "ENSG00000162975"}, {"source": "ENSG00000156486", "target": "ENSG00000164794"}, {"source": "ENSG00000156486", "target": "ENSG00000166006"}, {"source": "ENSG00000156486", "target": "ENSG00000168263"}, {"source": "ENSG00000156486", "target": "ENSG00000168418"}, {"source": "ENSG00000156486", "target": "ENSG00000170745"}, {"source": "ENSG00000156486", "target": "ENSG00000171126"}, {"source": "ENSG00000156486", "target": "ENSG00000171385"}, {"source": "ENSG00000156486", "target": "ENSG00000173826"}, {"source": "ENSG00000156486", "target": "ENSG00000177272"}, {"source": "ENSG00000156486", "target": "ENSG00000177301"}, {"source": "ENSG00000156486", "target": "ENSG00000178342"}, {"source": "ENSG00000156486", "target": "ENSG00000182255"}, {"source": "ENSG00000156486", "target": "ENSG00000182674"}, {"source": "ENSG00000156486", "target": "ENSG00000183960"}, {"source": "ENSG00000156486", "target": "ENSG00000184156"}, {"source": "ENSG00000156486", "target": "ENSG00000184408"}, {"source": "ENSG00000156486", "target": "ENSG00000184611"}, {"source": "ENSG00000156486", "target": "ENSG00000185760"}, {"source": "ENSG00000158445", "target": "ENSG00000162975"}, {"source": "ENSG00000158445", "target": "ENSG00000164794"}, {"source": "ENSG00000158445", "target": "ENSG00000166006"}, {"source": "ENSG00000158445", "target": "ENSG00000168263"}, {"source": "ENSG00000158445", "target": "ENSG00000168418"}, {"source": "ENSG00000158445", "target": "ENSG00000170745"}, {"source": "ENSG00000158445", "target": "ENSG00000171126"}, {"source": "ENSG00000158445", "target": "ENSG00000171385"}, {"source": "ENSG00000158445", "target": "ENSG00000173826"}, {"source": "ENSG00000158445", "target": "ENSG00000177272"}, {"source": "ENSG00000158445", "target": "ENSG00000177301"}, {"source": "ENSG00000158445", "target": "ENSG00000178342"}, {"source": "ENSG00000158445", "target": "ENSG00000182255"}, {"source": "ENSG00000158445", "target": "ENSG00000182674"}, {"source": "ENSG00000158445", "target": "ENSG00000183960"}, {"source": "ENSG00000158445", "target": "ENSG00000184156"}, {"source": "ENSG00000158445", "target": "ENSG00000184408"}, {"source": "ENSG00000158445", "target": "ENSG00000184611"}, {"source": "ENSG00000158445", "target": "ENSG00000185760"}, {"source": "ENSG00000162975", "target": "ENSG00000164794"}, {"source": "ENSG00000162975", "target": "ENSG00000166006"}, {"source": "ENSG00000162975", "target": "ENSG00000168263"}, {"source": "ENSG00000162975", "target": "ENSG00000168418"}, {"source": "ENSG00000162975", "target": "ENSG00000170745"}, {"source": "ENSG00000162975", "target": "ENSG00000171126"}, {"source": "ENSG00000162975", "target": "ENSG00000171385"}, {"source": "ENSG00000162975", "target": "ENSG00000173826"}, {"source": "ENSG00000162975", "target": "ENSG00000177272"}, {"source": "ENSG00000162975", "target": "ENSG00000177301"}, {"source": "ENSG00000162975", "target": "ENSG00000178342"}, {"source": "ENSG00000162975", "target": "ENSG00000182255"}, {"source": "ENSG00000162975", "target": "ENSG00000182674"}, {"source": "ENSG00000162975", "target": "ENSG00000183960"}, {"source": "ENSG00000162975", "target": "ENSG00000184156"}, {"source": "ENSG00000162975", "target": "ENSG00000184408"}, {"source": "ENSG00000162975", "target": "ENSG00000184611"}, {"source": "ENSG00000162975", "target": "ENSG00000185760"}, {"source": "ENSG00000164794", "target": "ENSG00000166006"}, {"source": "ENSG00000164794", "target": "ENSG00000168263"}, {"source": "ENSG00000164794", "target": "ENSG00000168418"}, {"source": "ENSG00000164794", "target": "ENSG00000170745"}, {"source": "ENSG00000164794", "target": "ENSG00000171126"}, {"source": "ENSG00000164794", "target": "ENSG00000171385"}, {"source": "ENSG00000164794", "target": "ENSG00000173826"}, {"source": "ENSG00000164794", "target": "ENSG00000177272"}, {"source": "ENSG00000164794", "target": "ENSG00000177301"}, {"source": "ENSG00000164794", "target": "ENSG00000178342"}, {"source": "ENSG00000164794", "target": "ENSG00000182255"}, {"source": "ENSG00000164794", "target": "ENSG00000182674"}, {"source": "ENSG00000164794", "target": "ENSG00000183960"}, {"source": "ENSG00000164794", "target": "ENSG00000184156"}, {"source": "ENSG00000164794", "target": "ENSG00000184408"}, {"source": "ENSG00000164794", "target": "ENSG00000184611"}, {"source": "ENSG00000164794", "target": "ENSG00000185760"}, {"source": "ENSG00000166006", "target": "ENSG00000168263"}, {"source": "ENSG00000166006", "target": "ENSG00000168418"}, {"source": "ENSG00000166006", "target": "ENSG00000170745"}, {"source": "ENSG00000166006", "target": "ENSG00000171126"}, {"source": "ENSG00000166006", "target": "ENSG00000171385"}, {"source": "ENSG00000166006", "target": "ENSG00000173826"}, {"source": "ENSG00000166006", "target": "ENSG00000177272"}, {"source": "ENSG00000166006", "target": "ENSG00000177301"}, {"source": "ENSG00000166006", "target": "ENSG00000178342"}, {"source": "ENSG00000166006", "target": "ENSG00000182255"}, {"source": "ENSG00000166006", "target": "ENSG00000182674"}, {"source": "ENSG00000166006", "target": "ENSG00000183960"}, {"source": "ENSG00000166006", "target": "ENSG00000184156"}, {"source": "ENSG00000166006", "target": "ENSG00000184408"}, {"source": "ENSG00000166006", "target": "ENSG00000184611"}, {"source": "ENSG00000166006", "target": "ENSG00000185760"}, {"source": "ENSG00000168263", "target": "ENSG00000168418"}, {"source": "ENSG00000168263", "target": "ENSG00000170745"}, {"source": "ENSG00000168263", "target": "ENSG00000171126"}, {"source": "ENSG00000168263", "target": "ENSG00000171385"}, {"source": "ENSG00000168263", "target": "ENSG00000173826"}, {"source": "ENSG00000168263", "target": "ENSG00000177272"}, {"source": "ENSG00000168263", "target": "ENSG00000177301"}, {"source": "ENSG00000168263", "target": "ENSG00000178342"}, {"source": "ENSG00000168263", "target": "ENSG00000182255"}, {"source": "ENSG00000168263", "target": "ENSG00000182674"}, {"source": "ENSG00000168263", "target": "ENSG00000183960"}, {"source": "ENSG00000168263", "target": "ENSG00000184156"}, {"source": "ENSG00000168263", "target": "ENSG00000184408"}, {"source": "ENSG00000168263", "target": "ENSG00000184611"}, {"source": "ENSG00000168263", "target": "ENSG00000185760"}, {"source": "ENSG00000168418", "target": "ENSG00000170745"}, {"source": "ENSG00000168418", "target": "ENSG00000171126"}, {"source": "ENSG00000168418", "target": "ENSG00000171385"}, {"source": "ENSG00000168418", "target": "ENSG00000173826"}, {"source": "ENSG00000168418", "target": "ENSG00000177272"}, {"source": "ENSG00000168418", "target": "ENSG00000177301"}, {"source": "ENSG00000168418", "target": "ENSG00000178342"}, {"source": "ENSG00000168418", "target": "ENSG00000182255"}, {"source": "ENSG00000168418", "target": "ENSG00000182674"}, {"source": "ENSG00000168418", "target": "ENSG00000183960"}, {"source": "ENSG00000168418", "target": "ENSG00000184156"}, {"source": "ENSG00000168418", "target": "ENSG00000184408"}, {"source": "ENSG00000168418", "target": "ENSG00000184611"}, {"source": "ENSG00000168418", "target": "ENSG00000185760"}, {"source": "ENSG00000170745", "target": "ENSG00000171126"}, {"source": "ENSG00000170745", "target": "ENSG00000171385"}, {"source": "ENSG00000170745", "target": "ENSG00000173826"}, {"source": "ENSG00000170745", "target": "ENSG00000177272"}, {"source": "ENSG00000170745", "target": "ENSG00000177301"}, {"source": "ENSG00000170745", "target": "ENSG00000178342"}, {"source": "ENSG00000170745", "target": "ENSG00000182255"}, {"source": "ENSG00000170745", "target": "ENSG00000182674"}, {"source": "ENSG00000170745", "target": "ENSG00000183960"}, {"source": "ENSG00000170745", "target": "ENSG00000184156"}, {"source": "ENSG00000170745", "target": "ENSG00000184408"}, {"source": "ENSG00000170745", "target": "ENSG00000184611"}, {"source": "ENSG00000170745", "target": "ENSG00000185760"}, {"source": "ENSG00000171126", "target": "ENSG00000171385"}, {"source": "ENSG00000171126", "target": "ENSG00000173826"}, {"source": "ENSG00000171126", "target": "ENSG00000177272"}, {"source": "ENSG00000171126", "target": "ENSG00000177301"}, {"source": "ENSG00000171126", "target": "ENSG00000178342"}, {"source": "ENSG00000171126", "target": "ENSG00000182255"}, {"source": "ENSG00000171126", "target": "ENSG00000182674"}, {"source": "ENSG00000171126", "target": "ENSG00000183960"}, {"source": "ENSG00000171126", "target": "ENSG00000184156"}, {"source": "ENSG00000171126", "target": "ENSG00000184408"}, {"source": "ENSG00000171126", "target": "ENSG00000184611"}, {"source": "ENSG00000171126", "target": "ENSG00000185760"}, {"source": "ENSG00000171385", "target": "ENSG00000173826"}, {"source": "ENSG00000171385", "target": "ENSG00000177272"}, {"source": "ENSG00000171385", "target": "ENSG00000177301"}, {"source": "ENSG00000171385", "target": "ENSG00000178342"}, {"source": "ENSG00000171385", "target": "ENSG00000182132"}, {"source": "ENSG00000171385", "target": "ENSG00000182255"}, {"source": "ENSG00000171385", "target": "ENSG00000182674"}, {"source": "ENSG00000171385", "target": "ENSG00000183960"}, {"source": "ENSG00000171385", "target": "ENSG00000184156"}, {"source": "ENSG00000171385", "target": "ENSG00000184408"}, {"source": "ENSG00000171385", "target": "ENSG00000184611"}, {"source": "ENSG00000171385", "target": "ENSG00000185760"}, {"source": "ENSG00000173826", "target": "ENSG00000177272"}, {"source": "ENSG00000173826", "target": "ENSG00000177301"}, {"source": "ENSG00000173826", "target": "ENSG00000178342"}, {"source": "ENSG00000173826", "target": "ENSG00000182255"}, {"source": "ENSG00000173826", "target": "ENSG00000182674"}, {"source": "ENSG00000173826", "target": "ENSG00000183960"}, {"source": "ENSG00000173826", "target": "ENSG00000184156"}, {"source": "ENSG00000173826", "target": "ENSG00000184408"}, {"source": "ENSG00000173826", "target": "ENSG00000184611"}, {"source": "ENSG00000173826", "target": "ENSG00000185760"}, {"source": "ENSG00000177272", "target": "ENSG00000177301"}, {"source": "ENSG00000177272", "target": "ENSG00000178342"}, {"source": "ENSG00000177272", "target": "ENSG00000182255"}, {"source": "ENSG00000177272", "target": "ENSG00000182674"}, {"source": "ENSG00000177272", "target": "ENSG00000183960"}, {"source": "ENSG00000177272", "target": "ENSG00000184156"}, {"source": "ENSG00000177272", "target": "ENSG00000184408"}, {"source": "ENSG00000177272", "target": "ENSG00000184611"}, {"source": "ENSG00000177272", "target": "ENSG00000185760"}, {"source": "ENSG00000177301", "target": "ENSG00000178342"}, {"source": "ENSG00000177301", "target": "ENSG00000182255"}, {"source": "ENSG00000177301", "target": "ENSG00000182674"}, {"source": "ENSG00000177301", "target": "ENSG00000183960"}, {"source": "ENSG00000177301", "target": "ENSG00000184156"}, {"source": "ENSG00000177301", "target": "ENSG00000184408"}, {"source": "ENSG00000177301", "target": "ENSG00000184611"}, {"source": "ENSG00000177301", "target": "ENSG00000185760"}, {"source": "ENSG00000178342", "target": "ENSG00000182255"}, {"source": "ENSG00000178342", "target": "ENSG00000182674"}, {"source": "ENSG00000178342", "target": "ENSG00000183960"}, {"source": "ENSG00000178342", "target": "ENSG00000184156"}, {"source": "ENSG00000178342", "target": "ENSG00000184408"}, {"source": "ENSG00000178342", "target": "ENSG00000184611"}, {"source": "ENSG00000178342", "target": "ENSG00000185760"}, {"source": "ENSG00000182132", "target": "ENSG00000184408"}, {"source": "ENSG00000182255", "target": "ENSG00000182674"}, {"source": "ENSG00000182255", "target": "ENSG00000183960"}, {"source": "ENSG00000182255", "target": "ENSG00000184156"}, {"source": "ENSG00000182255", "target": "ENSG00000184408"}, {"source": "ENSG00000182255", "target": "ENSG00000184611"}, {"source": "ENSG00000182255", "target": "ENSG00000185760"}, {"source": "ENSG00000182674", "target": "ENSG00000183960"}, {"source": "ENSG00000182674", "target": "ENSG00000184156"}, {"source": "ENSG00000182674", "target": "ENSG00000184408"}, {"source": "ENSG00000182674", "target": "ENSG00000184611"}, {"source": "ENSG00000182674", "target": "ENSG00000185760"}, {"source": "ENSG00000183960", "target": "ENSG00000184156"}, {"source": "ENSG00000183960", "target": "ENSG00000184408"}, {"source": "ENSG00000183960", "target": "ENSG00000184611"}, {"source": "ENSG00000183960", "target": "ENSG00000185760"}, {"source": "ENSG00000184156", "target": "ENSG00000184408"}, {"source": "ENSG00000184156", "target": "ENSG00000184611"}, {"source": "ENSG00000184156", "target": "ENSG00000185760"}, {"source": "ENSG00000184408", "target": "ENSG00000184611"}, {"source": "ENSG00000184408", "target": "ENSG00000185760"}, {"source": "ENSG00000184611", "target": "ENSG00000185760"}], "drugs": [{"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}, {"efo_term": "CEREBRAL PALSY", "stage": 1}], "max_phase": 4, "name": "DALFAMPRIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284348", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNG1", "KCNQ1", "KCNH2", "KCNQ2", "KCNH4", "KCND1", "KCNA7", "KCNA1", "KCNC4", "KCNQ4", "KCNS1", "KCNC1", "KCNA5", "KCNC3", "KCNH3", "KCNH5", "KCNA10", "KCNH1", "KCNA6", "KCNS2", "KCNB1", "KCNF1", "KCNV1", "KCNC2", "KCNV2", "KCNG4", "KCNS3", "KCNG3", "KCND3", "KCNH6", "KCNA3", "KCNA2", "KCNG2", "KCNA4", "KCNB2", "KCNH8", "KCNQ3", "KCND2", "KCNH7", "KCNQ5"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY", "PARKINSON'S DISEASE", "OBSTRUCTIVE SLEEP APNEA", "PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3", "CEREBRAL PALSY", "STROKE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "EZOGABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41355", "mechanisms": ["KCNQ (Kv7) potassium channel blocker"], "genes": ["KCNQ1", "KCNQ2", "KCNQ4", "KCNQ3", "KCNQ5"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "AMYOTROPHIC LATERAL SCLEROSIS", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}, {"efo_term": "PROLONGED QT INTERVAL", "stage": 1}], "max_phase": 4, "name": "DOFETILIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473", "mechanisms": ["HERG blocker"], "genes": ["KCNH2"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA", "PROLONGED QT INTERVAL"]}, {"indications": [{"efo_term": "VENTRICULAR TACHYCARDIA", "stage": 4}, {"efo_term": "VENTRICULAR FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "AMIODARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1083993", "mechanisms": ["HERG blocker"], "genes": ["KCNH2"], "type": "Small molecule", "diseases": ["VENTRICULAR TACHYCARDIA", "VENTRICULAR FIBRILLATION"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 3, "name": "TEDISAMIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113461", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNG1", "KCNQ1", "KCNH2", "KCNQ2", "KCNH4", "KCND1", "KCNA7", "KCNA1", "KCNC4", "KCNQ4", "KCNS1", "KCNC1", "KCNA5", "KCNC3", "KCNH3", "KCNH5", "KCNA10", "KCNH1", "KCNA6", "KCNS2", "KCNB1", "KCNF1", "KCNV1", "KCNC2", "KCNV2", "KCNG4", "KCNS3", "KCNG3", "KCND3", "KCNH6", "KCNA3", "KCNA2", "KCNG2", "KCNA4", "KCNB2", "KCNH8", "KCNQ3", "KCND2", "KCNH7", "KCNQ5"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNG1", "KCNQ1", "KCNH2", "KCNQ2", "KCNH4", "KCND1", "KCNA7", "KCNA1", "KCNC4", "KCNQ4", "KCNS1", "KCNC1", "KCNA5", "KCNC3", "KCNH3", "KCNH5", "KCNA10", "KCNH1", "KCNA6", "KCNS2", "KCNB1", "KCNF1", "KCNV1", "KCNC2", "KCNV2", "KCNG4", "KCNS3", "KCNG3", "KCND3", "KCNH6", "KCNA3", "KCNA2", "KCNG2", "KCNA4", "KCNB2", "KCNH8", "KCNQ3", "KCND2", "KCNH7", "KCNQ5"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["HERG blocker"], "genes": ["KCNH2"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [], "max_phase": 4, "name": "GUANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200728", "mechanisms": ["Voltage-gated potassium channel blocker"], "genes": ["KCNG1", "KCNQ1", "KCNH2", "KCNQ2", "KCNH4", "KCND1", "KCNA7", "KCNA1", "KCNC4", "KCNQ4", "KCNS1", "KCNC1", "KCNA5", "KCNC3", "KCNH3", "KCNH5", "KCNA10", "KCNH1", "KCNA6", "KCNS2", "KCNB1", "KCNF1", "KCNV1", "KCNC2", "KCNV2", "KCNG4", "KCNS3", "KCNG3", "KCND3", "KCNH6", "KCNA3", "KCNA2", "KCNG2", "KCNA4", "KCNB2", "KCNH8", "KCNQ3", "KCND2", "KCNH7", "KCNQ5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SOTALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1700", "mechanisms": ["HERG blocker"], "genes": ["KCNH2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "IBUTILIDE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200564", "mechanisms": ["HERG blocker"], "genes": ["KCNH2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD7009", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545040", "mechanisms": ["HERG blocker"], "genes": ["KCNH2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "FLINDOKALNER", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266510", "mechanisms": ["Voltage-gated potassium channel subunit Kv7.2 activator", "Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) activator", "Voltage-gated potassium channel subunit Kv7.4 activator", "Voltage-gated potassium channel KCNQ3/KCNQ4 activator", "Voltage-gated potassium channel subunit Kv7.5 activator"], "genes": ["KCNQ2", "KCNQ4", "KCNQ3", "KCNQ5"], "type": "Small molecule", "diseases": []}], "heat": 0.9394660496046511, "nodes": [{"assoc": 1.0, "id": "ENSG00000026559", "label": "KCNG1"}, {"assoc": 1.0, "id": "ENSG00000053918", "label": "KCNQ1"}, {"assoc": 1.0, "id": "ENSG00000055118", "label": "KCNH2"}, {"assoc": 1.0, "id": "ENSG00000075043", "label": "KCNQ2"}, {"assoc": 1.0, "id": "ENSG00000089558", "label": "KCNH4"}, {"assoc": 1.0, "id": "ENSG00000102057", "label": "KCND1"}, {"assoc": 1.0, "id": "ENSG00000104848", "label": "KCNA7"}, {"assoc": 1.0, "id": "ENSG00000111262", "label": "KCNA1"}, {"assoc": 1.0, "id": "ENSG00000116396", "label": "KCNC4"}, {"assoc": 1.0, "id": "ENSG00000117013", "label": "KCNQ4"}, {"assoc": 1.0, "id": "ENSG00000124134", "label": "KCNS1"}, {"assoc": 1.0, "id": "ENSG00000129159", "label": "KCNC1"}, {"assoc": 1.0, "id": "ENSG00000130037", "label": "KCNA5"}, {"assoc": 0.0352, "id": "ENSG00000130226", "label": "DPP6"}, {"assoc": 1.0, "id": "ENSG00000131398", "label": "KCNC3"}, {"assoc": 1.0, "id": "ENSG00000135519", "label": "KCNH3"}, {"assoc": 1.0, "id": "ENSG00000140015", "label": "KCNH5"}, {"assoc": 1.0, "id": "ENSG00000143105", "label": "KCNA10"}, {"assoc": 1.0, "id": "ENSG00000143473", "label": "KCNH1"}, {"assoc": 1.0, "id": "ENSG00000151079", "label": "KCNA6"}, {"assoc": 1.0, "id": "ENSG00000156486", "label": "KCNS2"}, {"assoc": 0.2902887002, "id": "ENSG00000157554", "label": "ERG"}, {"assoc": 1.0, "id": "ENSG00000158445", "label": "KCNB1"}, {"assoc": 1.0, "id": "ENSG00000162975", "label": "KCNF1"}, {"assoc": 1.0, "id": "ENSG00000164794", "label": "KCNV1"}, {"assoc": 1.0, "id": "ENSG00000166006", "label": "KCNC2"}, {"assoc": 1.0, "id": "ENSG00000168263", "label": "KCNV2"}, {"assoc": 1.0, "id": "ENSG00000168418", "label": "KCNG4"}, {"assoc": 1.0, "id": "ENSG00000170745", "label": "KCNS3"}, {"assoc": 1.0, "id": "ENSG00000171126", "label": "KCNG3"}, {"assoc": 1.0, "id": "ENSG00000171385", "label": "KCND3"}, {"assoc": 1.0, "id": "ENSG00000173826", "label": "KCNH6"}, {"assoc": 1.0, "id": "ENSG00000177272", "label": "KCNA3"}, {"assoc": 1.0, "id": "ENSG00000177301", "label": "KCNA2"}, {"assoc": 1.0, "id": "ENSG00000178342", "label": "KCNG2"}, {"assoc": 0.0715514328, "id": "ENSG00000182132", "label": "KCNIP1"}, {"assoc": 1.0, "id": "ENSG00000182255", "label": "KCNA4"}, {"assoc": 1.0, "id": "ENSG00000182674", "label": "KCNB2"}, {"assoc": 1.0, "id": "ENSG00000183960", "label": "KCNH8"}, {"assoc": 1.0, "id": "ENSG00000184156", "label": "KCNQ3"}, {"assoc": 1.0, "id": "ENSG00000184408", "label": "KCND2"}, {"assoc": 1.0, "id": "ENSG00000184611", "label": "KCNH7"}, {"assoc": 1.0, "id": "ENSG00000185760", "label": "KCNQ5"}], "size": 43}, {"diseases": ["INSOMNIA", "OBSESSIVE-COMPULSIVE DISORDER", "EPILEPSY", "SEIZURES", "ANXIETY", "PAIN", "HEART DISEASE", "INJURY", "DRUG DEPENDENCE", "NEUROPATHIC PAIN", "MARIJUANA DEPENDENCE", "LEUKEMIA", "MIGRAINE DISORDER", "MORBID OBESITY", "RESPIRATORY INSUFFICIENCY", "HYPERTENSION", "SUBARACHNOID HEMORRHAGE", "HYPOTENSION", "CORONARY ARTERY DISEASE", "PREMATURE BIRTH", "OBSTRUCTIVE SLEEP APNEA", "UNIPOLAR DEPRESSION", "INFLAMMATION", "DEMENTIA", "ANXIETY DISORDER", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "STROKE", "DRAVET SYNDROME", "LENNOX-GASTAUT SYNDROME", "OPIOID DEPENDENCE", "INGUINAL HERNIA", "FEVER", "CANCER", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "ACUTE RESPIRATORY DISTRESS SYNDROME", "ACUTE KIDNEY INJURY", "POST-OPERATIVE SIGN OR SYMPTOM", "COLORECTAL ADENOCARCINOMA", "AUTISM SPECTRUM DISORDER"], "links": [{"source": "ENSG00000022355", "target": "ENSG00000109158"}, {"source": "ENSG00000022355", "target": "ENSG00000113327"}, {"source": "ENSG00000022355", "target": "ENSG00000145863"}, {"source": "ENSG00000022355", "target": "ENSG00000145864"}, {"source": "ENSG00000022355", "target": "ENSG00000151834"}, {"source": "ENSG00000022355", "target": "ENSG00000163288"}, {"source": "ENSG00000022355", "target": "ENSG00000166206"}, {"source": "ENSG00000022355", "target": "ENSG00000182256"}, {"source": "ENSG00000022355", "target": "ENSG00000186297"}, {"source": "ENSG00000109158", "target": "ENSG00000113327"}, {"source": "ENSG00000109158", "target": "ENSG00000145863"}, {"source": "ENSG00000109158", "target": "ENSG00000145864"}, {"source": "ENSG00000109158", "target": "ENSG00000151834"}, {"source": "ENSG00000109158", "target": "ENSG00000163288"}, {"source": "ENSG00000109158", "target": "ENSG00000166206"}, {"source": "ENSG00000109158", "target": "ENSG00000182256"}, {"source": "ENSG00000109158", "target": "ENSG00000186297"}, {"source": "ENSG00000113327", "target": "ENSG00000145863"}, {"source": "ENSG00000113327", "target": "ENSG00000145864"}, {"source": "ENSG00000113327", "target": "ENSG00000151834"}, {"source": "ENSG00000113327", "target": "ENSG00000163288"}, {"source": "ENSG00000113327", "target": "ENSG00000166206"}, {"source": "ENSG00000113327", "target": "ENSG00000182256"}, {"source": "ENSG00000113327", "target": "ENSG00000186297"}, {"source": "ENSG00000145863", "target": "ENSG00000145864"}, {"source": "ENSG00000145863", "target": "ENSG00000151834"}, {"source": "ENSG00000145863", "target": "ENSG00000163288"}, {"source": "ENSG00000145863", "target": "ENSG00000166206"}, {"source": "ENSG00000145863", "target": "ENSG00000182256"}, {"source": "ENSG00000145863", "target": "ENSG00000186297"}, {"source": "ENSG00000145864", "target": "ENSG00000151834"}, {"source": "ENSG00000145864", "target": "ENSG00000163288"}, {"source": "ENSG00000145864", "target": "ENSG00000166206"}, {"source": "ENSG00000145864", "target": "ENSG00000182256"}, {"source": "ENSG00000145864", "target": "ENSG00000186297"}, {"source": "ENSG00000151834", "target": "ENSG00000163288"}, {"source": "ENSG00000151834", "target": "ENSG00000166206"}, {"source": "ENSG00000151834", "target": "ENSG00000182256"}, {"source": "ENSG00000151834", "target": "ENSG00000186297"}, {"source": "ENSG00000163288", "target": "ENSG00000166206"}, {"source": "ENSG00000163288", "target": "ENSG00000182256"}, {"source": "ENSG00000163288", "target": "ENSG00000186297"}, {"source": "ENSG00000166206", "target": "ENSG00000182256"}, {"source": "ENSG00000166206", "target": "ENSG00000186297"}, {"source": "ENSG00000182256", "target": "ENSG00000186297"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000139112", "type": "manual", "target": "ENSG00000163288"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000139112"}], "drugs": [{"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "RESPIRATORY INSUFFICIENCY", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "MORBID OBESITY", "stage": 2}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "PROPOFOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["LEUKEMIA", "MIGRAINE DISORDER", "MORBID OBESITY", "PAIN", "RESPIRATORY INSUFFICIENCY", "HYPERTENSION", "SUBARACHNOID HEMORRHAGE", "HYPOTENSION", "EPILEPSY", "INJURY", "CORONARY ARTERY DISEASE", "INSOMNIA", "PREMATURE BIRTH", "OBSTRUCTIVE SLEEP APNEA", "UNIPOLAR DEPRESSION", "INFLAMMATION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DEMENTIA", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "LORAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL580", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY", "DEMENTIA", "EPILEPSY", "UNIPOLAR DEPRESSION", "ANXIETY DISORDER", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE", "DRUG DEPENDENCE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "MORBID OBESITY", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}, {"efo_term": "HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "SEVOFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["OBESITY", "ACUTE KIDNEY INJURY", "CANCER", "MORBID OBESITY", "POST-OPERATIVE SIGN OR SYMPTOM", "HEART DISEASE", "INJURY", "CORONARY ARTERY DISEASE", "INFLAMMATION", "CONGENITAL HEART DISEASE"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "DRAVET SYNDROME", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 4, "name": "CLOBAZAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70418", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY", "DRAVET SYNDROME", "NEUROPATHIC PAIN", "PAIN", "LENNOX-GASTAUT SYNDROME"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "DIAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "ANXIETY", "PAIN"]}, {"indications": [{"efo_term": "PANIC DISORDER", "stage": 4}, {"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}], "max_phase": 4, "name": "ALPRAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["PANIC DISORDER", "ANXIETY", "POST-TRAUMATIC STRESS DISORDER", "ANXIETY DISORDER"]}, {"indications": [{"efo_term": "INJURY", "stage": 3}, {"efo_term": "HEART DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "PENTOBARBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["HEART DISEASE", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 4, "name": "CLONAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "EPILEPSY", "MARIJUANA DEPENDENCE"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 3}], "max_phase": 4, "name": "METHOXYFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["FEVER", "PAIN", "CANCER"]}, {"indications": [{"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 1}], "max_phase": 4, "name": "FLUMAZENIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407", "mechanisms": ["GABA-A receptor; anion channel allosteric antagonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "INGUINAL HERNIA", "stage": 3}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "ISOFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE", "INGUINAL HERNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}], "max_phase": 4, "name": "ESZOPICLONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA", "OBSTRUCTIVE SLEEP APNEA"]}, {"indications": [{"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}], "max_phase": 4, "name": "DESFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["POST-OPERATIVE SIGN OR SYMPTOM", "COLORECTAL ADENOCARCINOMA"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}], "max_phase": 2, "name": "AZD7325", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1783282", "mechanisms": ["GABA receptor alpha-2 subunit positive allosteric modulator"], "genes": ["GABRA2"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER", "ANXIETY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "METHARBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "CHLORDIAZEPOXIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "OXAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL568", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 3}], "max_phase": 4, "name": "ETOMIDATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}], "max_phase": 4, "name": "TEMAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL967", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "PRAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL969", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "HALAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL970", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "MEPROBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979", "mechanisms": ["GABA-A receptor; anion channel agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 3}], "max_phase": 4, "name": "MIDAZOLAM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200420", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-06372865", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707402", "mechanisms": ["GABA-A receptor; anion channel agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ADIPIPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103791", "mechanisms": ["GABA-A receptor; benzodiazepine site partial agonist"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "RESEQUINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107801", "mechanisms": ["GABA-A receptor; benzodiazepine site inverse agonist"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 4, "name": "ZALEPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1521", "mechanisms": ["GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator"], "genes": ["GABRA1", "GABRG2", "GABRB1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}], "max_phase": 4, "name": "ZOLPIDEM TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1723343", "mechanisms": ["GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator"], "genes": ["GABRA1", "GABRG2", "GABRB1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "ETAZOLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL356388", "mechanisms": ["GABA receptor beta-3 subunit positive allosteric modulator"], "genes": ["GABRB3"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [], "max_phase": 3, "name": "INDIPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL262075", "mechanisms": ["GABA receptor alpha-1 subunit positive allosteric modulator"], "genes": ["GABRA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTALBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL454", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETHCHLORVYNOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL591", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOPENTAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL738", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHOHEXITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30219", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ESTAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285674", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOTHANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENTOBARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL971", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GLUTETHIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1102", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ENFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200472", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLURAZEPAM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200602", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200703", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRICLOFOS SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200789", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYPRYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200790", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TALBUTAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200802", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SECOBARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200903", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTABARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200982", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIAMYLAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201065", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CLORAZEPATE DIPOTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096631", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "Lorediplon", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707317", "mechanisms": ["GABA-A receptor; benzodiazepine site positive allosteric modulator"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "GABOXADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312443", "mechanisms": ["GABA-A receptor; agonist GABA site agonist"], "genes": ["GABRA1", "GABRA4", "GABRA6", "GABRB2", "GABRA2", "GABRB1", "GABRB3", "GABRA5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD6280", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1783256", "mechanisms": ["GABA receptor alpha-2 subunit positive allosteric modulator"], "genes": ["GABRA2"], "type": "Small molecule", "diseases": []}], "heat": 0.7, "nodes": [{"assoc": 0.75, "id": "ENSG00000022355", "label": "GABRA1"}, {"assoc": 0.75, "id": "ENSG00000094755", "label": "GABRP"}, {"assoc": 0.75, "id": "ENSG00000102287", "label": "GABRE"}, {"assoc": 0.75, "id": "ENSG00000109158", "label": "GABRA4"}, {"assoc": 0.75, "id": "ENSG00000113327", "label": "GABRG2"}, {"assoc": 0.75, "id": "ENSG00000145863", "label": "GABRA6"}, {"assoc": 0.75, "id": "ENSG00000145864", "label": "GABRB2"}, {"assoc": 0.75, "id": "ENSG00000151834", "label": "GABRA2"}, {"assoc": 0.75, "id": "ENSG00000163285", "label": "GABRG1"}, {"assoc": 0.75, "id": "ENSG00000163288", "label": "GABRB1"}, {"assoc": 0.75, "id": "ENSG00000166206", "label": "GABRB3"}, {"assoc": 0.75, "id": "ENSG00000182256", "label": "GABRG3"}, {"assoc": 0.75, "id": "ENSG00000186297", "label": "GABRA5"}, {"assoc": 0.75, "id": "ENSG00000187730", "label": "GABRD"}, {"assoc": 0, "id": "ENSG00000139112", "label": "GABARAPL1"}], "size": 15}, {"diseases": ["HEPATITIS B INFECTION", "FRIEDREICH ATAXIA", "RETINOPATHY", "MULTIPLE MYELOMA", "MELANOMA", "OVARIAN CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "MALE BREAST CARCINOMA", "LYMPHOMA", "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA", "ULCERATIVE COLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC KIDNEY DISEASE", "ISCHEMIA REPERFUSION INJURY", "ACUTE MYELOID LEUKEMIA", "UVEITIS", "LEUKEMIA", "METASTATIC MELANOMA", "RENAL CARCINOMA", "TYPE I DIABETES MELLITUS", "CANCER", "HIV INFECTION", "RENAL CELL CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "CUTANEOUS MELANOMA", "NEUROBLASTOMA", "BREAST CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "NEPHROTIC SYNDROME", "LIVER DISEASE", "ALOPECIA AREATA", "PSORIASIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS", "NEUTROPENIA", "NON-HODGKINS LYMPHOMA", "BREAST NEOPLASM", "LYMPHOID NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "CIRRHOSIS OF LIVER", "CHAGAS CARDIOMYOPATHY", "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "INFERTILITY", "MYELODYSPLASTIC SYNDROME", "SARCOMA", "PARKINSON'S DISEASE", "RESPIRATORY FAILURE", "NEOPLASM OF MATURE B-CELLS", "PROSTATE CARCINOMA", "HEPATITIS, ALCOHOLIC", "RETINOBLASTOMA", "PERIPHERAL ARTERIAL DISEASE", "EWING SARCOMA", "NEUROMYELITIS OPTICA", "HEPATITIS C INFECTION", "CHRONIC HEPATITIS C INFECTION", "INFECTION", "ASTHMA", "ALZHEIMERS DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME", "CHRONIC HEPATITIS B INFECTION", "PRIMARY MYELOFIBROSIS", "CHRONIC MYELOGENOUS LEUKEMIA", "HEPATITIS D", "INFLUENZA INFECTION", "HIV-1 INFECTION", "RENAL INSUFFICIENCY", "HEPATOCELLULAR CARCINOMA", "ASTROCYTOMA", "CARCINOID TUMOR", "SEVERE ACUTE RESPIRATORY SYNDROME", "CHRONIC CHILDHOOD ARTHRITIS", "RHEUMATOID ARTHRITIS", "SCHIZOPHRENIA", "SYSTEMIC SCLERODERMA", "SJOGREN SYNDROME", "MYOCARDIAL INFARCTION", "ANKYLOSING SPONDYLITIS", "FIBROUS DYSPLASIA OF BONE", "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "PULMONARY HYPERTENSION", "DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION", "GRAVES OPHTHALMOPATHY", "ATOPIC ECZEMA", "CROHN'S DISEASE", "PSORIATIC ARTHRITIS", "SARCOIDOSIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "HIDRADENITIS SUPPURATIVA"], "links": [{"source": "ENSG00000027697", "target": "ENSG00000159128"}, {"source": "ENSG00000027697", "target": "ENSG00000168811"}, {"source": "ENSG00000100385", "target": "ENSG00000134460"}, {"source": "ENSG00000100385", "target": "ENSG00000147168"}, {"source": "ENSG00000100385", "target": "ENSG00000168811"}, {"source": "ENSG00000119535", "target": "ENSG00000168811"}, {"source": "ENSG00000134352", "target": "ENSG00000138378"}, {"source": "ENSG00000134352", "target": "ENSG00000160712"}, {"source": "ENSG00000134352", "target": "ENSG00000168811"}, {"source": "ENSG00000134460", "target": "ENSG00000138378"}, {"source": "ENSG00000134460", "target": "ENSG00000147168"}, {"source": "ENSG00000134460", "target": "ENSG00000168811"}, {"source": "ENSG00000138378", "target": "ENSG00000168811"}, {"source": "ENSG00000142166", "target": "ENSG00000159110"}, {"source": "ENSG00000142166", "target": "ENSG00000168811"}, {"source": "ENSG00000147168", "target": "ENSG00000168685"}, {"source": "ENSG00000147168", "target": "ENSG00000168811"}, {"source": "ENSG00000159110", "target": "ENSG00000168811"}, {"source": "ENSG00000159128", "target": "ENSG00000168811"}, {"source": "ENSG00000160712", "target": "ENSG00000168811"}, {"source": "ENSG00000164485", "target": "ENSG00000168811"}, {"source": "ENSG00000168685", "target": "ENSG00000168811"}], "drugs": [{"indications": [{"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "CHAGAS CARDIOMYOPATHY", "stage": 3}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 3}, {"efo_term": "MULTIPLE MYELOMA", "stage": 3}, {"efo_term": "NEUTROPENIA", "stage": 3}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "RETINOBLASTOMA", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "RESPIRATORY FAILURE", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 2}, {"efo_term": "INFERTILITY", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}, {"efo_term": "PERIPHERAL ARTERIAL DISEASE", "stage": 1}], "max_phase": 4, "name": "FILGRASTIM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201567", "mechanisms": ["Granulocyte colony stimulating factor receptor agonist"], "genes": ["CSF3R"], "type": "Protein", "diseases": ["CIRRHOSIS OF LIVER", "LEUKEMIA", "NEOPLASM", "CHAGAS CARDIOMYOPATHY", "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "ACUTE MYELOID LEUKEMIA", "INFERTILITY", "MULTIPLE MYELOMA", "NON-SMALL CELL LUNG CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "NEUTROPENIA", "MYELODYSPLASTIC SYNDROME", "LYMPHOMA", "SARCOMA", "PARKINSON'S DISEASE", "RESPIRATORY FAILURE", "BREAST CARCINOMA", "NEOPLASM OF MATURE B-CELLS", "NON-HODGKINS LYMPHOMA", "LYMPHOID NEOPLASM", "PROSTATE CARCINOMA", "HEPATITIS, ALCOHOLIC", "RETINOBLASTOMA", "PERIPHERAL ARTERIAL DISEASE"]}, {"indications": [{"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 3}, {"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "FIBROUS DYSPLASIA OF BONE", "stage": 2}, {"efo_term": "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "TOCILIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237022", "mechanisms": ["Interleukin-6 receptor alpha subunit inhibitor"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["CHRONIC CHILDHOOD ARTHRITIS", "RHEUMATOID ARTHRITIS", "SCHIZOPHRENIA", "SYSTEMIC SCLERODERMA", "SJOGREN SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "MYOCARDIAL INFARCTION", "ANKYLOSING SPONDYLITIS", "FIBROUS DYSPLASIA OF BONE", "PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "IMMUNE SYSTEM DISEASE", "PULMONARY HYPERTENSION", "ACUTE MYELOID LEUKEMIA", "AMYOTROPHIC LATERAL SCLEROSIS", "DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION", "UVEITIS", "TYPE I DIABETES MELLITUS", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "METASTATIC MELANOMA", "stage": 4}, {"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "RENAL CARCINOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "ULCERATIVE COLITIS", "stage": 1}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "NEUROBLASTOMA", "stage": 1}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 1}, {"efo_term": "ALOPECIA AREATA", "stage": 1}], "max_phase": 4, "name": "HUMAN INTERLEUKIN-2", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201438", "mechanisms": ["Interleukin-2 receptor agonist"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Protein", "diseases": ["LEUKEMIA", "METASTATIC MELANOMA", "RENAL CARCINOMA", "TYPE I DIABETES MELLITUS", "ULCERATIVE COLITIS", "ACUTE MYELOID LEUKEMIA", "CANCER", "HIV INFECTION", "RENAL CELL CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "NEOPLASM", "MELANOMA", "CUTANEOUS MELANOMA", "NEUROBLASTOMA", "BREAST CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "NEPHROTIC SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "LIVER DISEASE", "ALOPECIA AREATA"]}, {"indications": [{"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 4}, {"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "CHRONIC HEPATITIS B INFECTION", "stage": 3}, {"efo_term": "HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "MULTIPLE MYELOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}, {"efo_term": "HIV-1 INFECTION", "stage": 2}, {"efo_term": "ASTROCYTOMA", "stage": 2}, {"efo_term": "CARCINOID TUMOR", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 4, "name": "PEGINTERFERON ALFA-2B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201561", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CHRONIC HEPATITIS B INFECTION", "CHRONIC HEPATITIS C INFECTION", "HEPATITIS C INFECTION", "MELANOMA", "HIV-1 INFECTION", "CHRONIC MYELOGENOUS LEUKEMIA", "MULTIPLE MYELOMA", "RENAL INSUFFICIENCY", "HEPATOCELLULAR CARCINOMA", "ASTROCYTOMA", "CARCINOID TUMOR", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "USTEKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201835", "mechanisms": ["Interleukin-12 inhibitor"], "genes": ["IL12A"], "type": "Antibody", "diseases": ["ANKYLOSING SPONDYLITIS", "ATOPIC ECZEMA", "PSORIASIS", "CROHN'S DISEASE", "PSORIATIC ARTHRITIS", "SARCOIDOSIS", "TYPE I DIABETES MELLITUS", "IMMUNE SYSTEM DISEASE", "UVEITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ULCERATIVE COLITIS", "HIDRADENITIS SUPPURATIVA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 1}, {"efo_term": "UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA", "stage": 1}], "max_phase": 4, "name": "DENILEUKIN DIFTITOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201550", "mechanisms": ["Interleukin-2 receptor binding agent"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Protein", "diseases": ["MULTIPLE MYELOMA", "MELANOMA", "OVARIAN CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "MALE BREAST CARCINOMA", "LYMPHOMA", "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA"]}, {"indications": [{"efo_term": "CHRONIC HEPATITIS B INFECTION", "stage": 4}, {"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 4}, {"efo_term": "HEPATITIS C INFECTION", "stage": 4}, {"efo_term": "HEPATITIS B INFECTION", "stage": 4}, {"efo_term": "HEPATITIS B INFECTION", "stage": 4}, {"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "HEPATITIS D", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "PRIMARY MYELOFIBROSIS", "stage": 2}], "max_phase": 4, "name": "PEGINTERFERON ALFA-2A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201560", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CHRONIC HEPATITIS B INFECTION", "CHRONIC HEPATITIS C INFECTION", "HEPATITIS C INFECTION", "HIV INFECTION", "MELANOMA", "HEPATITIS B INFECTION", "PRIMARY MYELOFIBROSIS", "CHRONIC MYELOGENOUS LEUKEMIA", "HEPATITIS D"]}, {"indications": [{"efo_term": "NEUTROPENIA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}], "max_phase": 4, "name": "PEGFILGRASTIM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201568", "mechanisms": ["Granulocyte colony stimulating factor receptor agonist"], "genes": ["CSF3R"], "type": "Protein", "diseases": ["NEUTROPENIA", "LEUKEMIA", "NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA", "BREAST CARCINOMA", "LYMPHOMA", "BREAST NEOPLASM", "LYMPHOID NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 3}, {"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 2}, {"efo_term": "INFECTION", "stage": 2}, {"efo_term": "HEPATITIS C INFECTION", "stage": 1}, {"efo_term": "OVARIAN CARCINOMA", "stage": 1}, {"efo_term": "LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "INTERFERON ALFA-2B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201558", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CANCER", "HEPATITIS C INFECTION", "NEOPLASM", "OVARIAN CARCINOMA", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "MELANOMA", "LEUKEMIA", "INFECTION"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ISCHEMIA REPERFUSION INJURY", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "BASILIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201439", "mechanisms": ["Interleukin-2 receptor inhibitor"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Antibody", "diseases": ["NEOPLASM", "ULCERATIVE COLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC KIDNEY DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "ISCHEMIA REPERFUSION INJURY", "ACUTE MYELOID LEUKEMIA", "UVEITIS"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 4, "name": "INTERFERON BETA-1A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201562", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "ULCERATIVE COLITIS", "ASTHMA", "HEPATITIS C INFECTION", "ALZHEIMERS DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 1}], "max_phase": 4, "name": "DACLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201605", "mechanisms": ["Interleukin-2 receptor inhibitor"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Antibody", "diseases": ["PSORIASIS", "IMMUNE SYSTEM DISEASE", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 3}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 1}], "max_phase": 4, "name": "INTERFERON ALFA-2A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108508", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CANCER", "MELANOMA", "RENAL CELL CARCINOMA", "PSORIASIS"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 2}], "max_phase": 3, "name": "SARILUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108730", "mechanisms": ["Interleukin-6 receptor alpha subunit antagonist"], "genes": ["IL6R"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "ANKYLOSING SPONDYLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC CHILDHOOD ARTHRITIS"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 3, "name": "BRIAKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742995", "mechanisms": ["Interleukin-12 inhibitor"], "genes": ["IL12A"], "type": "Antibody", "diseases": ["IMMUNE SYSTEM DISEASE", "PSORIASIS", "MULTIPLE SCLEROSIS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "HEPATITIS B INFECTION", "stage": 2}, {"efo_term": "FRIEDREICH ATAXIA", "stage": 2}, {"efo_term": "RETINOPATHY", "stage": 1}], "max_phase": 4, "name": "INTERFERON GAMA-1B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201564", "mechanisms": ["Interferon gamma receptor agonist"], "genes": ["IFNGR1", "IFNGR2"], "type": "Protein", "diseases": ["HEPATITIS B INFECTION", "FRIEDREICH ATAXIA", "RETINOPATHY"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "FRIEDREICH ATAXIA", "stage": 3}], "max_phase": 4, "name": "INTERFERON BETA-1B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201563", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS", "FRIEDREICH ATAXIA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 4, "name": "PEGINTERFERON BETA-1A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108677", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 3}, {"efo_term": "EWING SARCOMA", "stage": 1}], "max_phase": 4, "name": "LIPEGFILGRASTIM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105765", "mechanisms": ["Granulocyte colony stimulating factor receptor agonist"], "genes": ["CSF3R"], "type": "Small molecule", "diseases": ["LYMPHOMA", "EWING SARCOMA"]}, {"indications": [{"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}], "max_phase": 2, "name": "LMB-2", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109367", "mechanisms": ["Interleukin-2 receptor alpha chain binding agent"], "genes": ["IL2RA"], "type": "Antibody", "diseases": ["LEUKEMIA", "LYMPHOMA"]}, {"indications": [{"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 2}, {"efo_term": "CHRONIC HEPATITIS B INFECTION", "stage": 1}], "max_phase": 3, "name": "ALBINTERFERON ALFA-2B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107842", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["CHRONIC HEPATITIS C INFECTION", "CHRONIC HEPATITIS B INFECTION"]}, {"indications": [{"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "SEVERE ACUTE RESPIRATORY SYNDROME", "stage": 2}], "max_phase": 4, "name": "INTERFERON ALFA-N3", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109047", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["HIV INFECTION", "SEVERE ACUTE RESPIRATORY SYNDROME"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 2}], "max_phase": 2, "name": "BALUGRASTIM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108572", "mechanisms": ["Granulocyte colony stimulating factor receptor agonist"], "genes": ["CSF3R"], "type": "Protein", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "NEUROMYELITIS OPTICA", "stage": 3}], "max_phase": 0, "name": "SA237", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833307", "mechanisms": ["IL6Ralpha/GP130 antagonist"], "genes": ["IL6ST", "IL6R"], "type": "Antibody", "diseases": ["NEUROMYELITIS OPTICA"]}, {"indications": [{"efo_term": "INFLUENZA INFECTION", "stage": 1}], "max_phase": 4, "name": "INTERFERON ALFACON-1", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201557", "mechanisms": ["Interferon alpha/beta receptor agonist"], "genes": ["IFNAR1", "IFNAR2"], "type": "Protein", "diseases": ["INFLUENZA INFECTION"]}, {"indications": [], "max_phase": 2, "name": "INOLIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108370", "mechanisms": ["Interleukin-2 receptor alpha chain antagonist"], "genes": ["IL2RA"], "type": "Antibody", "diseases": []}], "heat": 0.8650875702541427, "nodes": [{"assoc": 1.0, "id": "ENSG00000027697", "label": "IFNGR1"}, {"assoc": 1.0, "id": "ENSG00000100385", "label": "IL2RB"}, {"assoc": 0.736111111111, "id": "ENSG00000119535", "label": "CSF3R"}, {"assoc": 0.879577, "id": "ENSG00000134352", "label": "IL6ST"}, {"assoc": 1.0, "id": "ENSG00000134460", "label": "IL2RA"}, {"assoc": 0.504141681478, "id": "ENSG00000138378", "label": "STAT4"}, {"assoc": 1.0, "id": "ENSG00000142166", "label": "IFNAR1"}, {"assoc": 1.0, "id": "ENSG00000147168", "label": "IL2RG"}, {"assoc": 1.0, "id": "ENSG00000159110", "label": "IFNAR2"}, {"assoc": 1.0, "id": "ENSG00000159128", "label": "IFNGR2"}, {"assoc": 0.912481222222, "id": "ENSG00000160712", "label": "IL6R"}, {"assoc": 0.613451850686, "id": "ENSG00000164485", "label": "IL22RA2"}, {"assoc": 0.809006124918, "id": "ENSG00000168685", "label": "IL7R"}, {"assoc": 0.656456993143, "id": "ENSG00000168811", "label": "IL12A"}], "size": 14}, {"diseases": ["EPILEPSY", "LIVER DISEASE", "UNIPOLAR DEPRESSION", "PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS", "GAMBLING BEHAVIOUR", "BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "TINNITUS", "PAIN", "NEUROPATHIC PAIN", "OBSESSIVE-COMPULSIVE DISORDER", "SCHIZOPHRENIA", "MIGRAINE DISORDER", "ALCOHOL DRINKING", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "OBESITY", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "SEIZURES", "TORTICOLLIS", "ESSENTIAL TREMOR", "DIABETIC NEUROPATHY", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM SPECTRUM DISORDER", "DIABETIC RETINOPATHY"], "links": [{"source": "ENSG00000105464", "target": "ENSG00000152578"}, {"source": "ENSG00000105464", "target": "ENSG00000161509"}, {"source": "ENSG00000105464", "target": "ENSG00000176884"}, {"source": "ENSG00000105464", "target": "ENSG00000183454"}, {"source": "ENSG00000105737", "target": "ENSG00000163873"}, {"source": "ENSG00000105737", "target": "ENSG00000164418"}, {"source": "ENSG00000116032", "target": "ENSG00000152578"}, {"source": "ENSG00000116032", "target": "ENSG00000176884"}, {"source": "ENSG00000116032", "target": "ENSG00000183454"}, {"source": "ENSG00000116032", "target": "ENSG00000198785"}, {"source": "ENSG00000149403", "target": "ENSG00000164418"}, {"source": "ENSG00000152578", "target": "ENSG00000176884"}, {"source": "ENSG00000152578", "target": "ENSG00000183454"}, {"source": "ENSG00000152578", "target": "ENSG00000198785"}, {"source": "ENSG00000161509", "target": "ENSG00000176884"}, {"source": "ENSG00000161509", "target": "ENSG00000183454"}, {"source": "ENSG00000164418", "target": "ENSG00000171189"}, {"source": "ENSG00000164418", "target": "ENSG00000176884"}, {"source": "ENSG00000171189", "target": "ENSG00000176884"}, {"source": "ENSG00000176884", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000198785"}, {"source": "ENSG00000183454", "target": "ENSG00000198785"}], "drugs": [{"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Glutamate receptor ionotropic kainate antagonist", "Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIK5", "GRIK4", "GRIA4", "GRIK3", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "INFECTION", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "CEREBRAL ATHEROSCLEROSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "AMANTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1569", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "TORTICOLLIS", "stage": 1}], "max_phase": 4, "name": "PERAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1214124", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARKINSON'S DISEASE", "SEIZURES", "TORTICOLLIS", "NEUROPATHIC PAIN", "MIGRAINE DISORDER", "ESSENTIAL TREMOR", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "SUICIDAL IDEATION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "KETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1714", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "INJURY"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}], "max_phase": 2, "name": "Selurampanel", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545042", "mechanisms": ["Glutamate receptor ionotropic kainate antagonist", "Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIK5", "GRIK4", "GRIA4", "GRIK3", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "SEIZURES", "TINNITUS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395091", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["LIVER DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}], "max_phase": 4, "name": "MEMANTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1699", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["GAMBLING BEHAVIOUR", "CANCER"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 3, "name": "RAPASTINEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544917", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Protein", "diseases": ["OBSESSIVE-COMPULSIVE DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "NRX-1074", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545230", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 2, "name": "AV-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545351", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "FARAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276138", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "MK-8777", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707401", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "DIABETIC RETINOPATHY", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256818", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "FELBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "GW468816", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1207366", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "TINNITUS", "stage": 3}], "max_phase": 3, "name": "NERAMEXANE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106798", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["TINNITUS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LANICEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107647", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364609", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Indantadol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707400", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 2, "name": "TEZAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14935", "mechanisms": ["Glutamate receptor ionotropic kainate antagonist", "Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIK5", "GRIK4", "GRIA4", "GRIK3", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "MIBAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1277001", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "PF-04958242", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707379", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Radiprodil", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182066", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "CERC-301", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068839", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}], "max_phase": 4, "name": "DEXTROMETHORPHAN POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201461", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER"]}, {"indications": [], "max_phase": 0, "name": "CNS-5161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41306", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NEBOGLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255840", "mechanisms": ["Glutamate [NMDA] receptor positive allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DELUCEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110814", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD8108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707355", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ZONAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119625", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DASOLAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103869", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist", "Glutamate receptor ionotropic kainate 1 antagonist"], "genes": ["GRIA4", "GRIK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "BECAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107735", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CX1739", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707399", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRAXOPRODIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17350", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVT-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545349", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": []}], "heat": 0.625, "nodes": [{"assoc": 1.0, "id": "ENSG00000105464", "label": "GRIN2D"}, {"assoc": 0.25, "id": "ENSG00000105737", "label": "GRIK5"}, {"assoc": 1.0, "id": "ENSG00000116032", "label": "GRIN3B"}, {"assoc": 0.25, "id": "ENSG00000149403", "label": "GRIK4"}, {"assoc": 0.25, "id": "ENSG00000152578", "label": "GRIA4"}, {"assoc": 1.0, "id": "ENSG00000161509", "label": "GRIN2C"}, {"assoc": 0.25, "id": "ENSG00000163873", "label": "GRIK3"}, {"assoc": 0.25, "id": "ENSG00000164418", "label": "GRIK2"}, {"assoc": 0.25, "id": "ENSG00000171189", "label": "GRIK1"}, {"assoc": 1.0, "id": "ENSG00000176884", "label": "GRIN1"}, {"assoc": 1.0, "id": "ENSG00000183454", "label": "GRIN2A"}, {"assoc": 1.0, "id": "ENSG00000198785", "label": "GRIN3A"}], "size": 12}, {"diseases": ["ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "ATYPICAL HEMOLYTIC-UREMIC SYNDROME", "PAROXYSMAL NOCTURNAL HEMOGLOBINURIA", "MYASTHENIA GRAVIS", "AGE-RELATED MACULAR DEGENERATION", "CHRONIC KIDNEY DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "IMMUNE SYSTEM DISEASE", "NEUROMYELITIS OPTICA", "DIABETES MELLITUS", "THROMBOCYTOPENIA", "MYOCARDIAL INFARCTION", "CANCER", "OTITIS MEDIA", "PAIN", "ADENOMA", "SUBARACHNOID HEMORRHAGE", "MORBID OBESITY", "OBSTRUCTIVE SLEEP APNEA", "HYPOTENSION", "OPIOID DEPENDENCE", "OCCLUSIVE ARTERIAL DISEASE", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PARKINSON'S DISEASE", "DIABETIC NEUROPATHY", "KIDNEY STONE", "PRURITUS", "DYSPNEA", "COCAINE DEPENDENCE", "EATING DISORDER", "CONSTIPATION", "DIGESTIVE SYSTEM DISEASE", "HEROIN DEPENDENCE", "NEONATAL ABSTINENCE SYNDROME", "UNIPOLAR DEPRESSION", "DRUG DEPENDENCE", "HIV INFECTION", "LUMBAR DISC DEGENERATION", "EPILEPSY", "OBESITY", "DIARRHEA", "SCOLIOSIS", "NEUROPATHIC PAIN", "PREMATURE EJACULATION", "BREAST CARCINOMA", "HALLUX VALGUS", "IRRITABLE BOWEL SYNDROME", "ALCOHOL DEPENDENCE", "GAMBLING BEHAVIOUR", "ALCOHOL DRINKING", "METAMPHETAMINE DEPENDENCE", "CROHN'S DISEASE", "OBSESSIVE-COMPULSIVE DISORDER", "NICOTINE DEPENDENCE", "HAIR-PULLING", "MARIJUANA DEPENDENCE", "MULTIPLE SCLEROSIS", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "TYPE I DIABETES MELLITUS", "SCHIZOPHRENIA", "COUGH", "LIVER DISEASE", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "ANOREXIA NERVOSA", "NAUSEA", "ALZHEIMERS DISEASE", "SMOKING CESSATION", "ANXIETY", "NEOPLASM", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "TYPE II DIABETES MELLITUS", "POST OPERATIVE NAUSEA AND VOMITING", "SPASTICITY", "AMYOTROPHIC LATERAL SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "PSORIASIS", "INFLAMMATORY BOWEL DISEASE", "PREECLAMPSIA", "HYPERTENSION", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "GLAUCOMA", "CARDIOVASCULAR DISEASE", "MIGRAINE DISORDER", "SEPTIC SHOCK", "AUTISM SPECTRUM DISORDER", "CEREBRAL ISCHEMIA", "FIBROMYALGIA", "BONE NEOPLASM", "OPEN-ANGLE GLAUCOMA", "RETINITIS PIGMENTOSA", "HYPEREMIA", "OCULAR HYPERTENSION", "ROSACEA", "INCREASED INTRAOCULAR PRESSURE", "ALLERGIC CONJUNCTIVITIS", "INSOMNIA", "ALLERGIC RHINITIS", "EYE DISEASE", "RHINITIS", "GRAVES OPHTHALMOPATHY", "ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "RENAL INSUFFICIENCY", "ORTHOSTATIC HYPOTENSION", "MULTIPLE SYSTEM ATROPHY", "POLYMYOSITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "CUTANEOUS LUPUS ERYTHEMATOSUS"], "links": [{"source": "ENSG00000106804", "target": "ENSG00000112038"}, {"source": "ENSG00000106804", "target": "ENSG00000118432"}, {"source": "ENSG00000106804", "target": "ENSG00000125910"}, {"source": "ENSG00000106804", "target": "ENSG00000150594"}, {"source": "ENSG00000106804", "target": "ENSG00000170989"}, {"source": "ENSG00000106804", "target": "ENSG00000180739"}, {"source": "ENSG00000106804", "target": "ENSG00000184160"}, {"source": "ENSG00000106804", "target": "ENSG00000213694"}, {"source": "ENSG00000106804", "target": "ENSG00000267534"}, {"source": "ENSG00000112038", "target": "ENSG00000118432"}, {"source": "ENSG00000112038", "target": "ENSG00000125910"}, {"source": "ENSG00000112038", "target": "ENSG00000150594"}, {"source": "ENSG00000112038", "target": "ENSG00000170989"}, {"source": "ENSG00000112038", "target": "ENSG00000180739"}, {"source": "ENSG00000112038", "target": "ENSG00000184160"}, {"source": "ENSG00000112038", "target": "ENSG00000213694"}, {"source": "ENSG00000112038", "target": "ENSG00000267534"}, {"source": "ENSG00000118432", "target": "ENSG00000125910"}, {"source": "ENSG00000118432", "target": "ENSG00000150594"}, {"source": "ENSG00000118432", "target": "ENSG00000170989"}, {"source": "ENSG00000118432", "target": "ENSG00000180739"}, {"source": "ENSG00000118432", "target": "ENSG00000184160"}, {"source": "ENSG00000118432", "target": "ENSG00000213694"}, {"source": "ENSG00000118432", "target": "ENSG00000267534"}, {"source": "ENSG00000125910", "target": "ENSG00000150594"}, {"source": "ENSG00000125910", "target": "ENSG00000170989"}, {"source": "ENSG00000125910", "target": "ENSG00000180739"}, {"source": "ENSG00000125910", "target": "ENSG00000184160"}, {"source": "ENSG00000125910", "target": "ENSG00000213694"}, {"source": "ENSG00000125910", "target": "ENSG00000267534"}, {"source": "ENSG00000150594", "target": "ENSG00000170989"}, {"source": "ENSG00000150594", "target": "ENSG00000180739"}, {"source": "ENSG00000150594", "target": "ENSG00000184160"}, {"source": "ENSG00000150594", "target": "ENSG00000213694"}, {"source": "ENSG00000150594", "target": "ENSG00000267534"}, {"source": "ENSG00000170989", "target": "ENSG00000180739"}, {"source": "ENSG00000170989", "target": "ENSG00000184160"}, {"source": "ENSG00000170989", "target": "ENSG00000213694"}, {"source": "ENSG00000170989", "target": "ENSG00000267534"}, {"source": "ENSG00000180739", "target": "ENSG00000184160"}, {"source": "ENSG00000180739", "target": "ENSG00000213694"}, {"source": "ENSG00000180739", "target": "ENSG00000267534"}, {"source": "ENSG00000184160", "target": "ENSG00000213694"}, {"source": "ENSG00000184160", "target": "ENSG00000267534"}, {"source": "ENSG00000213694", "target": "ENSG00000267534"}], "drugs": [{"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 4}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "HAIR-PULLING", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "PAIN", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}], "max_phase": 4, "name": "NALTREXONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "GAMBLING BEHAVIOUR", "OPIOID DEPENDENCE", "ALCOHOL DRINKING", "HIV INFECTION", "OBESITY", "PAIN", "METAMPHETAMINE DEPENDENCE", "CROHN'S DISEASE", "HEROIN DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER", "NICOTINE DEPENDENCE", "HAIR-PULLING", "MARIJUANA DEPENDENCE", "MULTIPLE SCLEROSIS", "COCAINE DEPENDENCE", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "TYPE I DIABETES MELLITUS", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 3}, {"efo_term": "DRAVET SYNDROME", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PAIN", "stage": 1}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}], "max_phase": 3, "name": "CANNABIDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190461", "mechanisms": ["Cannabinoid CB1 receptor Negative allosteric modulator"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PAIN", "MARIJUANA DEPENDENCE", "ACUTE GRAFT VS. HOST DISEASE", "ANXIETY", "EPILEPSY", "NEOPLASM", "SEIZURES", "PARKINSON'S DISEASE", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "DRUG DEPENDENCE", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "COCAINE DEPENDENCE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 4}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 2}, {"efo_term": "CONSTIPATION", "stage": 2}, {"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "PRURITUS", "stage": 2}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "BUPRENORPHINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["HEROIN DEPENDENCE", "PAIN", "OPIOID DEPENDENCE", "NEONATAL ABSTINENCE SYNDROME", "OSTEOARTHRITIS", "UNIPOLAR DEPRESSION", "DRUG DEPENDENCE", "HIV INFECTION", "COCAINE DEPENDENCE", "LUMBAR DISC DEGENERATION", "CONSTIPATION", "EPILEPSY", "EATING DISORDER", "PRURITUS", "OBESITY"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 3}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 2}, {"efo_term": "SEPTIC SHOCK", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 1}], "max_phase": 4, "name": "CLONIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "GLAUCOMA", "HYPERTENSION", "PAIN", "CARDIOVASCULAR DISEASE", "MIGRAINE DISORDER", "NEONATAL ABSTINENCE SYNDROME", "SEPTIC SHOCK", "ANXIETY", "OPIOID DEPENDENCE", "MARIJUANA DEPENDENCE", "AUTISM SPECTRUM DISORDER", "CEREBRAL ISCHEMIA", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "ATYPICAL HEMOLYTIC-UREMIC SYNDROME", "stage": 4}, {"efo_term": "PAROXYSMAL NOCTURNAL HEMOGLOBINURIA", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "MYASTHENIA GRAVIS", "stage": 3}, {"efo_term": "NEUROMYELITIS OPTICA", "stage": 3}, {"efo_term": "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "THROMBOCYTOPENIA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}], "max_phase": 4, "name": "ECULIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201828", "mechanisms": ["Complement C5 inhibitor"], "genes": ["C5"], "type": "Antibody", "diseases": ["ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "ATYPICAL HEMOLYTIC-UREMIC SYNDROME", "PAROXYSMAL NOCTURNAL HEMOGLOBINURIA", "MYASTHENIA GRAVIS", "AGE-RELATED MACULAR DEGENERATION", "CHRONIC KIDNEY DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "IMMUNE SYSTEM DISEASE", "NEUROMYELITIS OPTICA", "DIABETES MELLITUS", "THROMBOCYTOPENIA"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ADENOMA", "stage": 3}, {"efo_term": "MORBID OBESITY", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 3}, {"efo_term": "OCCLUSIVE ARTERIAL DISEASE", "stage": 3}, {"efo_term": "OTITIS MEDIA", "stage": 2}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 2}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 1}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "FENTANYL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CANCER", "OTITIS MEDIA", "PAIN", "ADENOMA", "SUBARACHNOID HEMORRHAGE", "MORBID OBESITY", "OBSTRUCTIVE SLEEP APNEA", "HYPOTENSION", "IMMUNE SYSTEM DISEASE", "OPIOID DEPENDENCE", "OCCLUSIVE ARTERIAL DISEASE"]}, {"indications": [{"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 4}, {"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "DRONABINOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME", "MARIJUANA DEPENDENCE", "SCHIZOPHRENIA", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "OBSTRUCTIVE SLEEP APNEA", "ANOREXIA NERVOSA", "DRUG DEPENDENCE", "NAUSEA", "ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "PRURITUS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "OXYCODONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "CANCER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PARKINSON'S DISEASE", "DIABETIC NEUROPATHY", "KIDNEY STONE", "PRURITUS", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "ROSACEA", "stage": 4}, {"efo_term": "INCREASED INTRAOCULAR PRESSURE", "stage": 4}, {"efo_term": "HYPEREMIA", "stage": 3}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "RETINITIS PIGMENTOSA", "stage": 1}], "max_phase": 4, "name": "BRIMONIDINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062257", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "RETINITIS PIGMENTOSA", "HYPEREMIA", "OCULAR HYPERTENSION", "ROSACEA", "INCREASED INTRAOCULAR PRESSURE", "AGE-RELATED MACULAR DEGENERATION", "ALLERGIC CONJUNCTIVITIS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "MIRTAZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654", "mechanisms": ["Adrenergic receptor alpha-2 antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "EYE DISEASE", "stage": 3}, {"efo_term": "RHINITIS", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "OXYMETAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200791", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "PRURITUS", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 2}, {"efo_term": "HALLUX VALGUS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}], "max_phase": 4, "name": "MORPHINE SULFATE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103744", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["NEONATAL ABSTINENCE SYNDROME", "PAIN", "HALLUX VALGUS", "PRURITUS", "OSTEOARTHRITIS, KNEE"]}, {"indications": [{"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "SPASTICITY", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 1}], "max_phase": 4, "name": "NABILONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218896", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["NAUSEA", "POST OPERATIVE NAUSEA AND VOMITING", "SPASTICITY", "MARIJUANA DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 1}, {"efo_term": "INFLAMMATORY BOWEL DISEASE", "stage": 1}], "max_phase": 2, "name": "AMISELIMOD HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707374", "mechanisms": ["Sphingosine 1-phosphate receptor modulator"], "genes": ["S1PR4", "S1PR1", "S1PR5", "S1PR3", "S1PR2"], "type": "Small molecule", "diseases": ["RELAPSING-REMITTING MULTIPLE SCLEROSIS", "CROHN'S DISEASE", "SYSTEMIC LUPUS ERYTHEMATOSUS", "PSORIASIS", "INFLAMMATORY BOWEL DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "TAPENTADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201777", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "HYDROCODONE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062267", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "PAIN", "LIVER DISEASE", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "POLYMYOSITIS", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "Siponimod", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2336071", "mechanisms": ["Sphingosine 1-phosphate receptor Edg-1  agonist", "Sphingosine 1-phosphate receptor Edg-8 agonist"], "genes": ["S1PR1", "S1PR5"], "type": "Small molecule", "diseases": ["POLYMYOSITIS", "LIVER DISEASE", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "DYSPNEA", "stage": 0}], "max_phase": 4, "name": "FENTANYL CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL688", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "CANCER", "DYSPNEA"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 3}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "ALVIMOPAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL270190", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION", "CANCER", "DIGESTIVE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "TRAMADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237065", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "PREMATURE EJACULATION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 3, "name": "CEBRANOPADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364605", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "PONESIMOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096146", "mechanisms": ["Sphingosine 1-phosphate receptor Edg-1  agonist"], "genes": ["S1PR1"], "type": "Small molecule", "diseases": ["PSORIASIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "CUTANEOUS LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "KRP203", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545101", "mechanisms": ["Sphingosine 1-phosphate receptor Edg-1  agonist"], "genes": ["S1PR1"], "type": "Small molecule", "diseases": ["CUTANEOUS LUPUS ERYTHEMATOSUS", "ULCERATIVE COLITIS", "CANCER"]}, {"indications": [{"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 2, "name": "SAMIDORPHAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426084", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EATING DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "OXYCODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200890", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "NALOXONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1718", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE", "PAIN"]}, {"indications": [{"efo_term": "OBESITY", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "TARANABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220360", "mechanisms": ["Cannabinoid CB1 receptor inverse agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "IBIPINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL412262", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "FINGOLIMOD HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL544665", "mechanisms": ["Sphingosine 1-phosphate receptor agonist"], "genes": ["S1PR4", "S1PR1", "S1PR5", "S1PR3", "S1PR2"], "type": "Small molecule", "diseases": ["AMYOTROPHIC LATERAL SCLEROSIS", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "METHYLDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL459", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["PREECLAMPSIA", "HYPERTENSION"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 3}], "max_phase": 3, "name": "PEXELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107979", "mechanisms": ["Complement C5 inhibitor"], "genes": ["C5"], "type": "Antibody", "diseases": ["MYOCARDIAL INFARCTION"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "DEZOCINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1685", "mechanisms": ["Mu opioid receptor partial agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "MEPERIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1701", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "DIARRHEA", "stage": 3}], "max_phase": 4, "name": "LOPERAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1707", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["DIARRHEA"]}, {"indications": [{"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "METHADONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200825", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["SCOLIOSIS"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 4}], "max_phase": 4, "name": "METHYLNALTREXONE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201770", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "HYDROMORPHONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237055", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}], "max_phase": 4, "name": "NALDEMEDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105755", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "AXOMADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107731", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 4}], "max_phase": 4, "name": "ELUXADOLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2159122", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "METHYLSAMIDORPHAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364619", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "OPIOID DEPENDENCE", "stage": 4}], "max_phase": 4, "name": "Buprenorphine Hydrochloride", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2368861", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 3, "name": "OLICERIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2443262", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 4}], "max_phase": 4, "name": "NALDEMEDINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039508", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "AXELOPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137313", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "CODEINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284671", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "OXYMORPHONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200794", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "CODEINE PHOSPHATE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201099", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "NALBUPHINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201132", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "NALTREXONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201149", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}], "max_phase": 4, "name": "NALMEFENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201152", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "COUGH", "stage": 4}], "max_phase": 4, "name": "CODEINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201463", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["COUGH"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "ODELEPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103878", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 2, "name": "SURINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189676", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SMOKING CESSATION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "Drinabant", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545166", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "CLONIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1705", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 4}], "max_phase": 4, "name": "TIZANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200329", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["SPASTICITY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "GUANFACINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200494", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "BONE NEOPLASM", "stage": 1}], "max_phase": 4, "name": "GUANABENZ ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200560", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["BONE NEOPLASM"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "ESMIRTAZAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107339", "mechanisms": ["Adrenergic receptor alpha-2 antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RAUWOLFIA SERPENTINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3559672", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 2}], "max_phase": 2, "name": "APD334", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544938", "mechanisms": ["Sphingosine 1-phosphate receptor Edg-1  agonist"], "genes": ["S1PR1"], "type": "Small molecule", "diseases": ["ULCERATIVE COLITIS"]}, {"indications": [], "max_phase": 4, "name": "BUTORPHANOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299400", "mechanisms": ["Mu opioid receptor partial agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALFENTANIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200531", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANILERIDINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200543", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIFENOXIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200599", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYCODONE TEREPHTHALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200611", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENOXYLATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200665", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOMETHADYL ACETATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200817", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANILERIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201047", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "REMIFENTANIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201120", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FENTANYL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201159", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SUFENTANIL CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201163", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYPHENE NAPSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237085", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYPHENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237104", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVORPHANOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062261", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIHYDROCODEINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062266", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALLORPHAN TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062276", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FAXELADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103829", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FRAKEFAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105081", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NALOXEGOL OXALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219416", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BEVENOPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039511", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Naltalimide", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545408", "mechanisms": ["Mu opioid receptor partial agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROCODONE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201470", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "OTENABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL562668", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NONABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106841", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD2207", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545289", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SAD448", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545387", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVONORDEFRIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL677", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "APRACLONIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200379", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYLDOPATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200432", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXMEDETOMIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106195", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FADOLMIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106710", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NAPHAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1706", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRAHYDROZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200413", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENOXYBENZAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200787", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENTOLAMINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200873", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALSEROXYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201454", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ERGOTAMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062265", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}], "heat": 0.9886111111110999, "nodes": [{"assoc": 0.886111111111, "id": "ENSG00000106804", "label": "C5"}, {"assoc": 1.0, "id": "ENSG00000112038", "label": "OPRM1"}, {"assoc": 1.0, "id": "ENSG00000118432", "label": "CNR1"}, {"assoc": 1.0, "id": "ENSG00000125910", "label": "S1PR4"}, {"assoc": 1.0, "id": "ENSG00000150594", "label": "ADRA2A"}, {"assoc": 1.0, "id": "ENSG00000170989", "label": "S1PR1"}, {"assoc": 1.0, "id": "ENSG00000180739", "label": "S1PR5"}, {"assoc": 1.0, "id": "ENSG00000184160", "label": "ADRA2C"}, {"assoc": 1.0, "id": "ENSG00000213694", "label": "S1PR3"}, {"assoc": 1.0, "id": "ENSG00000267534", "label": "S1PR2"}], "size": 10}, {"diseases": ["CARDIOVASCULAR DISEASE", "NEPHROTIC SYNDROME", "CONGESTIVE HEART FAILURE", "CIRRHOSIS OF LIVER", "HYPERTENSION", "CARDIAC ARRHYTHMIA", "CYSTIC FIBROSIS", "EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA", "CATARACT", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "DRUG DEPENDENCE", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "OBSESSIVE-COMPULSIVE DISORDER", "ALCOHOL DEPENDENCE", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "NICOTINE DEPENDENCE", "MIGRAINE DISORDER", "NEUROPATHY", "DIABETIC NEUROPATHY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA", "COMPLEX PARTIAL EPILEPSY", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "DYSURIA", "ATRIAL FIBRILLATION", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE", "CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"], "links": [{"source": "ENSG00000111319", "target": "ENSG00000136531"}, {"source": "ENSG00000111319", "target": "ENSG00000166828"}, {"source": "ENSG00000111319", "target": "ENSG00000168447"}, {"source": "ENSG00000111319", "target": "ENSG00000183873"}, {"source": "ENSG00000111319", "target": "ENSG00000185313"}, {"source": "ENSG00000111319", "target": "ENSG00000196876"}, {"source": "ENSG00000136531", "target": "ENSG00000166828"}, {"source": "ENSG00000136531", "target": "ENSG00000168447"}, {"source": "ENSG00000136531", "target": "ENSG00000183873"}, {"source": "ENSG00000136531", "target": "ENSG00000185313"}, {"source": "ENSG00000136531", "target": "ENSG00000196876"}, {"source": "ENSG00000166828", "target": "ENSG00000168447"}, {"source": "ENSG00000166828", "target": "ENSG00000183873"}, {"source": "ENSG00000166828", "target": "ENSG00000185313"}, {"source": "ENSG00000166828", "target": "ENSG00000196876"}, {"source": "ENSG00000168447", "target": "ENSG00000183873"}, {"source": "ENSG00000168447", "target": "ENSG00000185313"}, {"source": "ENSG00000168447", "target": "ENSG00000196876"}, {"source": "ENSG00000183873", "target": "ENSG00000185313"}, {"source": "ENSG00000183873", "target": "ENSG00000196876"}, {"source": "ENSG00000185313", "target": "ENSG00000196876"}, {"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000149575"}, {"source": "ENSG00000149575", "type": "manual", "target": "ENSG00000168447"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000166257"}, {"source": "ENSG00000166257", "type": "manual", "target": "ENSG00000168447"}], "drugs": [{"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "COUGH", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "PARATHYROID DISEASE", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "URINARY TRACT INFECTION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "UTERINE FIBROID", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "TINNITUS", "stage": 0}], "max_phase": 4, "name": "LIDOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "MOOD DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 1}], "max_phase": 4, "name": "LAMOTRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EPILEPSY", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "PARTIAL EPILEPSY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 3}, {"efo_term": "DILATED CARDIOMYOPATHY", "stage": 2}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "PROLONGED QT INTERVAL", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIASTOLIC HEART FAILURE", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}], "max_phase": 4, "name": "RANOLAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"]}, {"indications": [{"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATAXIA", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "RILUZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "BIPOLAR DISORDER", "UNIPOLAR DEPRESSION", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CANCER", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "LACOSAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "OSTEOARTHRITIS", "PARTIAL EPILEPSY", "MIGRAINE DISORDER", "NEUROPATHY", "NEUROPATHIC PAIN", "FIBROMYALGIA", "SEIZURES", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COMPLEX PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}], "max_phase": 4, "name": "ESLICARBAZEPINE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "FIBROMYALGIA", "MIGRAINE DISORDER", "BIPOLAR DISORDER", "COMPLEX PARTIAL EPILEPSY", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ZONISAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "EPILEPSY", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "SEIZURES", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 4, "name": "OXCARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1068", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "PARTIAL EPILEPSY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 4}], "max_phase": 4, "name": "TRIAMTERENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL585", "mechanisms": ["Amiloride-sensitive sodium channel, ENaC blocker"], "genes": ["SCNN1A", "SCNN1G", "SCNN1B"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE", "NEPHROTIC SYNDROME", "CONGESTIVE HEART FAILURE", "CIRRHOSIS OF LIVER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}], "max_phase": 4, "name": "PHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "TRIGEMINAL NEURALGIA", "stage": 4}], "max_phase": 4, "name": "CARBAMAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA"]}, {"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CATARACT", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "TETRACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CATARACT", "PAIN", "PRURITUS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "RUFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SEIZURES", "EPILEPSY", "LENNOX-GASTAUT SYNDROME", "PAIN"]}, {"indications": [{"efo_term": "HIP FRACTURE", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "INGUINAL HERNIA", "stage": 1}, {"efo_term": "PAIN", "stage": 0}], "max_phase": 4, "name": "ROPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1889140", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "AMILORIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1398126", "mechanisms": ["Amiloride-sensitive sodium channel, ENaC blocker"], "genes": ["SCNN1A", "SCNN1G", "SCNN1B"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CONGESTIVE HEART FAILURE", "CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "TRIGEMINAL NEURALGIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}], "max_phase": 2, "name": "RAXATRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544913", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["TRIGEMINAL NEURALGIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "PF-05089771", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545171", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "CYSTIC FIBROSIS", "stage": 2}], "max_phase": 2, "name": "P-1037", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545352", "mechanisms": ["Amiloride-sensitive sodium channel, ENaC blocker"], "genes": ["SCNN1A", "SCNN1G", "SCNN1B"], "type": "Small molecule", "diseases": ["CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "MEPHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENACEMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL918", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ESLICARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL315985", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ETHOTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "DYSURIA", "stage": 3}], "max_phase": 4, "name": "PHENAZOPYRIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201022", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["DYSURIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "QUINIDINE POLYGALACTURONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201486", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "NW-3509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545207", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 1, "name": "AZD3161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545208", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-04531083", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544951", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Sodium channel protein type II alpha subunit blocker", "Sodium channel protein type III alpha subunit blocker"], "genes": ["SCN2A", "SCN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FOSPHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLOROPROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1611", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1769", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MORICIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200334", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "INDECAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LIDOCAINE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200409", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE GLUCONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200437", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200440", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MERETHOXYLLINE PROCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200443", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPARACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200464", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DYCLONINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200586", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETIDOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200597", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEXILETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200606", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENOXINATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXYLCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200715", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOCAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200773", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ARTICAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200819", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200841", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DISOPYRAMIDE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201020", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "NKTR-171", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545209", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707183", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DSP-2230", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545012", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN9A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "XEN403", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545091", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG7893", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707353", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG6029", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707380", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIBUCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200612", "mechanisms": ["Sodium channel protein type V alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN5A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLECAINIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200822", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD7009", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545040", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": []}], "heat": 0.6000000000000001, "nodes": [{"assoc": 0.2, "id": "ENSG00000111319", "label": "SCNN1A"}, {"assoc": 1.0, "id": "ENSG00000136531", "label": "SCN2A"}, {"assoc": 1.0, "id": "ENSG00000153253", "label": "SCN3A"}, {"assoc": 0.2, "id": "ENSG00000166828", "label": "SCNN1G"}, {"assoc": 0.2, "id": "ENSG00000168447", "label": "SCNN1B"}, {"assoc": 1.0, "id": "ENSG00000169432", "label": "SCN9A"}, {"assoc": 1.0, "id": "ENSG00000183873", "label": "SCN5A"}, {"assoc": 1.0, "id": "ENSG00000185313", "label": "SCN10A"}, {"assoc": 1.0, "id": "ENSG00000196876", "label": "SCN8A"}, {"assoc": 0, "id": "ENSG00000149575", "label": "SCN2B"}, {"assoc": 0, "id": "ENSG00000166257", "label": "SCN3B"}], "size": 11}, {"diseases": ["RHEUMATOID ARTHRITIS", "SJOGREN SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "ANKYLOSING SPONDYLITIS", "CHRONIC CHILDHOOD ARTHRITIS", "DERMATOMYOSITIS", "PSORIASIS", "SUBARACHNOID HEMORRHAGE", "TYPE I DIABETES MELLITUS", "SCIATICA", "CHRONIC KIDNEY DISEASE", "LEUKEMIA", "URTICARIA", "ISCHEMIA REPERFUSION INJURY", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "PNEUMONIA", "ALZHEIMERS DISEASE", "LICHEN PLANUS", "HIDRADENITIS SUPPURATIVA", "INCLUSION BODY MYOSITIS", "ULCERATIVE COLITIS", "CROHN'S DISEASE", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "OSTEOARTHRITIS", "PSORIATIC ARTHRITIS", "NETHERTON SYNDROME", "SARCOIDOSIS", "PYODERMA", "COLITIS", "UVEITIS", "CHRONIC INTERSTITIAL CYSTITIS", "PAIN", "ENDOMETRIOSIS", "HEPATITIS C INFECTION", "EOSINOPHILIC ESOPHAGITIS", "SPONDYLOARTHROPATHY", "BERYLLIOSIS", "BEHCET'S SYNDROME", "BIPOLAR DISORDER", "DIABETIC RETINOPATHY", "ASTHMA"], "links": [{"source": "ENSG00000067182", "target": "ENSG00000118503"}, {"source": "ENSG00000067182", "target": "ENSG00000226979"}, {"source": "ENSG00000067182", "target": "ENSG00000232810"}, {"source": "ENSG00000118503", "target": "ENSG00000172175"}, {"source": "ENSG00000172175", "target": "ENSG00000198286"}, {"source": "ENSG00000226979", "target": "ENSG00000227507"}], "drugs": [{"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 3}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 3}, {"efo_term": "PNEUMONIA", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "URTICARIA", "stage": 2}, {"efo_term": "ISCHEMIA REPERFUSION INJURY", "stage": 2}, {"efo_term": "MUCOCUTANEOUS LYMPH NODE SYNDROME", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "LICHEN PLANUS", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "DERMATOMYOSITIS", "stage": 1}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 1}, {"efo_term": "SCIATICA", "stage": 1}, {"efo_term": "INCLUSION BODY MYOSITIS", "stage": 0}], "max_phase": 4, "name": "ETANERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201572", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Protein", "diseases": ["ACUTE GRAFT VS. HOST DISEASE", "ANKYLOSING SPONDYLITIS", "CHRONIC CHILDHOOD ARTHRITIS", "DERMATOMYOSITIS", "PSORIASIS", "RHEUMATOID ARTHRITIS", "SUBARACHNOID HEMORRHAGE", "TYPE I DIABETES MELLITUS", "SCIATICA", "CHRONIC KIDNEY DISEASE", "LEUKEMIA", "URTICARIA", "ISCHEMIA REPERFUSION INJURY", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "PNEUMONIA", "ALZHEIMERS DISEASE", "LICHEN PLANUS", "HIDRADENITIS SUPPURATIVA", "INCLUSION BODY MYOSITIS"]}, {"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "MUCOCUTANEOUS LYMPH NODE SYNDROME", "stage": 3}, {"efo_term": "BEHCET'S SYNDROME", "stage": 3}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 3}, {"efo_term": "ENDOMETRIOSIS", "stage": 2}, {"efo_term": "HEPATITIS C INFECTION", "stage": 2}, {"efo_term": "EOSINOPHILIC ESOPHAGITIS", "stage": 2}, {"efo_term": "SPONDYLOARTHROPATHY", "stage": 2}, {"efo_term": "COLITIS", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "BERYLLIOSIS", "stage": 1}, {"efo_term": "UVEITIS", "stage": 1}], "max_phase": 4, "name": "INFLIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201581", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "ENDOMETRIOSIS", "PSORIASIS", "RHEUMATOID ARTHRITIS", "ULCERATIVE COLITIS", "HEPATITIS C INFECTION", "EOSINOPHILIC ESOPHAGITIS", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "PSORIATIC ARTHRITIS", "SPONDYLOARTHROPATHY", "BERYLLIOSIS", "BEHCET'S SYNDROME", "COLITIS", "BIPOLAR DISORDER", "ACUTE GRAFT VS. HOST DISEASE", "DIABETIC RETINOPATHY", "UVEITIS", "HIDRADENITIS SUPPURATIVA"]}, {"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "CROHN'S DISEASE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 3}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 3}, {"efo_term": "UVEITIS", "stage": 3}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "stage": 2}, {"efo_term": "NETHERTON SYNDROME", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "PYODERMA", "stage": 2}, {"efo_term": "COLITIS", "stage": 2}], "max_phase": 4, "name": "ADALIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201580", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["ANKYLOSING SPONDYLITIS", "PSORIASIS", "RHEUMATOID ARTHRITIS", "ULCERATIVE COLITIS", "CROHN'S DISEASE", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "OSTEOARTHRITIS", "PSORIATIC ARTHRITIS", "NETHERTON SYNDROME", "SARCOIDOSIS", "CHRONIC CHILDHOOD ARTHRITIS", "PYODERMA", "COLITIS", "HIDRADENITIS SUPPURATIVA", "UVEITIS", "CHRONIC INTERSTITIAL CYSTITIS", "PAIN"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 4}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}], "max_phase": 4, "name": "CERTOLIZUMAB PEGOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201831", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "PSORIATIC ARTHRITIS", "ULCERATIVE COLITIS", "ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "CHRONIC CHILDHOOD ARTHRITIS", "PSORIASIS", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "SPONDYLOARTHROPATHY", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}], "max_phase": 4, "name": "GOLIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201833", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "SPONDYLOARTHROPATHY", "ULCERATIVE COLITIS", "ANKYLOSING SPONDYLITIS", "ASTHMA", "PSORIATIC ARTHRITIS", "SARCOIDOSIS", "TYPE I DIABETES MELLITUS"]}, {"indications": [{"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "BAMINERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742988", "mechanisms": ["Heterotrimeric lymphotoxin LTa1b2 inhibitor"], "genes": ["LTA", "LTB"], "type": "Protein", "diseases": ["SJOGREN SYNDROME", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "SCIATICA", "stage": 1}], "max_phase": 2, "name": "PLACULUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108739", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "SCIATICA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "PATECLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743056", "mechanisms": ["TNF-beta inhibitor"], "genes": ["LTA"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "OZORALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743054", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}], "max_phase": 3, "name": "ONERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107911", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Protein", "diseases": ["PSORIATIC ARTHRITIS"]}, {"indications": [], "max_phase": 2, "name": "PEGSUNERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743057", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 3, "name": "LENERCEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108208", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 3, "name": "NERELIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108566", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AFELIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108887", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZ-9773", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109587", "mechanisms": ["TNF-alpha inhibitor"], "genes": ["TNF"], "type": "Antibody", "diseases": []}], "heat": 0.3519345183665714, "nodes": [{"assoc": 1.0, "id": "ENSG00000067182", "label": "TNFRSF1A"}, {"assoc": 0.4188544583, "id": "ENSG00000118503", "label": "TNFAIP3"}, {"assoc": 0.3805488706, "id": "ENSG00000172175", "label": "MALT1"}, {"assoc": 0.3333333333, "id": "ENSG00000198286", "label": "CARD11"}, {"assoc": 0.113942088465, "id": "ENSG00000226979", "label": "LTA"}, {"assoc": 0.10481625, "id": "ENSG00000227507", "label": "LTB"}, {"assoc": 0.112046627901, "id": "ENSG00000232810", "label": "TNF"}], "size": 7}, {"diseases": ["GASTROESOPHAGEAL REFLUX DISEASE", "PEPTIC ULCER", "HEMORRHAGE", "GASTROINTESTINAL HEMORRHAGE", "GASTROPARESIS", "MOVEMENT DISORDER", "SCHIZOPHRENIA", "PSORIASIS", "PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE", "CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA", "DIABETIC FOOT", "COCAINE DEPENDENCE", "HUNTINGTON DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NEUROPATHIC PAIN", "NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS", "DYSPNEA", "MIGRAINE DISORDER", "AMBLYOPIA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "PREGNANCY", "MULTIPLE SCLEROSIS", "RHEUMATOID ARTHRITIS", "DIABETIC NEPHROPATHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "OPTIC NEURITIS", "SARCOIDOSIS", "ACUTE RESPIRATORY DISTRESS SYNDROME", "UVEITIS", "ADRENAL GLAND DISEASE", "OBESITY", "HEART FAILURE", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS", "HYPERTENSION", "CANCER", "EPILEPSY", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA", "OPEN-ANGLE GLAUCOMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "MULTIPLE SYSTEM ATROPHY"], "links": [{"source": "ENSG00000113749", "target": "ENSG00000128271"}, {"source": "ENSG00000113749", "target": "ENSG00000134453"}, {"source": "ENSG00000113749", "target": "ENSG00000170425"}, {"source": "ENSG00000113749", "target": "ENSG00000171522"}, {"source": "ENSG00000113749", "target": "ENSG00000185231"}, {"source": "ENSG00000113749", "target": "ENSG00000188778"}, {"source": "ENSG00000128271", "target": "ENSG00000170425"}, {"source": "ENSG00000128271", "target": "ENSG00000171522"}, {"source": "ENSG00000128271", "target": "ENSG00000185231"}, {"source": "ENSG00000128271", "target": "ENSG00000188778"}, {"source": "ENSG00000170425", "target": "ENSG00000171522"}, {"source": "ENSG00000170425", "target": "ENSG00000185231"}, {"source": "ENSG00000170425", "target": "ENSG00000188778"}, {"source": "ENSG00000171522", "target": "ENSG00000185231"}, {"source": "ENSG00000171522", "target": "ENSG00000188778"}, {"source": "ENSG00000185231", "target": "ENSG00000188778"}], "drugs": [{"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 0}, {"efo_term": "OPTIC NEURITIS", "stage": 0}], "max_phase": 4, "name": "CORTICOTROPIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201610", "mechanisms": ["Melanocortin receptor 2 agonist"], "genes": ["MC2R"], "type": "Protein", "diseases": ["MIGRAINE DISORDER", "MULTIPLE SCLEROSIS", "RHEUMATOID ARTHRITIS", "DIABETIC NEPHROPATHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "OPTIC NEURITIS", "SARCOIDOSIS", "ACUTE RESPIRATORY DISTRESS SYNDROME", "UVEITIS"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ENDOMETRIOSIS", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BILIARY ATRESIA", "stage": 2}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 2}, {"efo_term": "NECROTIZING ENTEROCOLITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "PENTOXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628", "mechanisms": ["Adenosine A2 receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "LEFT VENTRICULAR HYPERTROPHY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "MIRABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095212", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "PAIN", "LIVER DISEASE", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 4}, {"efo_term": "GASTROINTESTINAL HEMORRHAGE", "stage": 3}, {"efo_term": "MOVEMENT DISORDER", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 1}], "max_phase": 4, "name": "FAMOTIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902", "mechanisms": ["Histamine H2 receptor antagonist"], "genes": ["HRH2"], "type": "Small molecule", "diseases": ["MOVEMENT DISORDER", "PEPTIC ULCER", "GASTROESOPHAGEAL REFLUX DISEASE", "SCHIZOPHRENIA", "PSORIASIS", "GASTROINTESTINAL HEMORRHAGE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 2}, {"efo_term": "CORONARY HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "REGADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 4}, {"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "GASTROINTESTINAL HEMORRHAGE", "stage": 3}], "max_phase": 4, "name": "CIMETIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30", "mechanisms": ["Histamine H2 receptor antagonist"], "genes": ["HRH2"], "type": "Small molecule", "diseases": ["GASTROESOPHAGEAL REFLUX DISEASE", "PEPTIC ULCER", "HEMORRHAGE", "GASTROINTESTINAL HEMORRHAGE"]}, {"indications": [{"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 4}, {"efo_term": "GASTROPARESIS", "stage": 1}], "max_phase": 4, "name": "NIZATIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL653", "mechanisms": ["Histamine H2 receptor antagonist"], "genes": ["HRH2"], "type": "Small molecule", "diseases": ["PEPTIC ULCER", "GASTROESOPHAGEAL REFLUX DISEASE", "GASTROPARESIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "ISTRADEFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 4}], "max_phase": 4, "name": "RANITIDINE BISMUTH CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2111286", "mechanisms": ["Histamine H2 receptor antagonist"], "genes": ["HRH2"], "type": "Small molecule", "diseases": ["PEPTIC ULCER", "GASTROESOPHAGEAL REFLUX DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "PRELADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240624", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 0}], "max_phase": 3, "name": "TOZADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105747", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "V81444", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545288", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}], "max_phase": 4, "name": "DINOPROSTONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548", "mechanisms": ["Prostaglandin E2 receptor agonist"], "genes": ["PTGER4"], "type": "Small molecule", "diseases": ["PAIN", "PREGNANCY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 2, "name": "VIPADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447664", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "DIABETIC FOOT", "stage": 2}], "max_phase": 2, "name": "SONEDENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950553", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["DIABETIC FOOT"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545009", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-999", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545271", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "BVT.115959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545409", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "ADRENAL GLAND DISEASE", "stage": 1}], "max_phase": 4, "name": "COSYNTROPIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103784", "mechanisms": ["Melanocortin receptor 2 agonist"], "genes": ["MC2R"], "type": "Protein", "diseases": ["ADRENAL GLAND DISEASE"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}], "max_phase": 2, "name": "LY377604", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2012520", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 1}], "max_phase": 3, "name": "RITOBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107773", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 2}], "max_phase": 2, "name": "VIBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107826", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "ISOPROTERENOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARTEOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201002", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Histamine H2 receptor agonist"], "genes": ["HRH2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BETAZOLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200949", "mechanisms": ["Histamine H2 receptor agonist"], "genes": ["HRH2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHANTHELINE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200988", "mechanisms": ["Histamine H2 receptor antagonist"], "genes": ["HRH2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CIMETIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201051", "mechanisms": ["Histamine H2 receptor antagonist"], "genes": ["HRH2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RANITIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110372", "mechanisms": ["Histamine H2 receptor antagonist"], "genes": ["HRH2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ST1535", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL197669", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "UK432097", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096896", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BINODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950554", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "APADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950649", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950651", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GS 6201", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL260933", "mechanisms": ["Adenosine A2b receptor antagonist"], "genes": ["ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS101057", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1672627", "mechanisms": ["Adenosine A2b receptor antagonist"], "genes": ["ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "QAF805", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545204", "mechanisms": ["Adenosine A2b receptor antagonist"], "genes": ["ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RIVENPROST", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL303960", "mechanisms": ["Prostanoid EP4 receptor agonist"], "genes": ["PTGER4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CORTICOTROPIN ZINC HYDROXIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201609", "mechanisms": ["Melanocortin receptor 2 agonist"], "genes": ["MC2R"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SERACTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201489", "mechanisms": ["Melanocortin receptor 2 agonist"], "genes": ["MC2R"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RAFABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279260", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SOLABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL208427", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AMIBEGRON HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL545437", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200447", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}], "heat": 0.749725723416, "nodes": [{"assoc": 1.0, "id": "ENSG00000113749", "label": "HRH2"}, {"assoc": 0.7, "id": "ENSG00000128271", "label": "ADORA2A"}, {"assoc": 0.1681919164, "id": "ENSG00000134453", "label": "RBM17"}, {"assoc": 0.7, "id": "ENSG00000170425", "label": "ADORA2B"}, {"assoc": 0.679888147512, "id": "ENSG00000171522", "label": "PTGER4"}, {"assoc": 1.0, "id": "ENSG00000185231", "label": "MC2R"}, {"assoc": 1.0, "id": "ENSG00000188778", "label": "ADRB3"}], "size": 7}, {"diseases": ["BENIGN PROSTATIC HYPERPLASIA", "KIDNEY STONE", "PREMATURE EJACULATION", "PROSTATE CARCINOMA", "PROSTATITIS", "UNIPOLAR DEPRESSION", "HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "CATARACT", "CARDIAC ARRHYTHMIA", "STROKE", "HYPERPLASIA", "POST-OPERATIVE SIGN OR SYMPTOM", "NEUROGENIC BLADDER", "ASTHMA", "ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY", "EOSINOPHILIC ESOPHAGITIS", "RHINITIS, ALLERGIC, PERENNIAL", "ALLERGY", "PAIN", "ATOPIC ECZEMA", "FISH-EYE DISEASE", "ECZEMA", "PRURITUS", "SKIN DISEASE", "NEUROTIC DISORDER", "VASOMOTOR RHINITIS", "EYE ALLERGY", "INSOMNIA"], "links": [{"source": "ENSG00000120907", "target": "ENSG00000170214"}, {"source": "ENSG00000120907", "target": "ENSG00000171873"}, {"source": "ENSG00000120907", "target": "ENSG00000173198"}, {"source": "ENSG00000120907", "target": "ENSG00000196639"}, {"source": "ENSG00000170214", "target": "ENSG00000171873"}, {"source": "ENSG00000170214", "target": "ENSG00000173198"}, {"source": "ENSG00000170214", "target": "ENSG00000196639"}, {"source": "ENSG00000171873", "target": "ENSG00000173198"}, {"source": "ENSG00000171873", "target": "ENSG00000196639"}, {"source": "ENSG00000173198", "target": "ENSG00000196639"}], "drugs": [{"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGY", "stage": 4}, {"efo_term": "URTICARIA", "stage": 3}, {"efo_term": "ATOPIC ECZEMA", "stage": 3}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "DESLORATADINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1172", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "URTICARIA", "ATOPIC ECZEMA", "SEASONAL ALLERGIC RHINITIS", "FISH-EYE DISEASE", "ALLERGY", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "EYE DISEASE", "stage": 3}, {"efo_term": "RHINITIS", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "OXYMETAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200791", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 2}, {"efo_term": "PROSTATITIS", "stage": 2}], "max_phase": 4, "name": "SILODOSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24778", "mechanisms": ["Alpha-1a adrenergic receptor antagonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "KIDNEY STONE", "PREMATURE EJACULATION", "PROSTATE CARCINOMA", "PROSTATITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}, {"efo_term": "EOSINOPHILIC ESOPHAGITIS", "stage": 1}], "max_phase": 4, "name": "MONTELUKAST SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200681", "mechanisms": ["Cysteinyl leukotriene receptor 1 antagonist"], "genes": ["CYSLTR1"], "type": "Small molecule", "diseases": ["ASTHMA", "EOSINOPHILIC ESOPHAGITIS", "ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}, {"efo_term": "VASOMOTOR RHINITIS", "stage": 4}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "AZELASTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200809", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC CONJUNCTIVITIS", "VASOMOTOR RHINITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}, {"efo_term": "HYPERPLASIA", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}], "max_phase": 4, "name": "TAMSULOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200914", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "HYPERPLASIA", "POST-OPERATIVE SIGN OR SYMPTOM", "NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 2}], "max_phase": 4, "name": "LORATADINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["SEASONAL ALLERGIC RHINITIS", "ALLERGY", "PAIN", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 3}, {"efo_term": "ECZEMA", "stage": 3}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "KETOTIFEN FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1633", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ATOPIC ECZEMA", "ALLERGIC CONJUNCTIVITIS", "ECZEMA", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}, {"efo_term": "PRURITUS", "stage": 4}], "max_phase": 4, "name": "OLOPATADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1719", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC CONJUNCTIVITIS", "PRURITUS"]}, {"indications": [{"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SKIN DISEASE", "stage": 4}, {"efo_term": "NEUROTIC DISORDER", "stage": 4}, {"efo_term": "PRURITUS", "stage": 4}], "max_phase": 4, "name": "HYDROXYZINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200467", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["URTICARIA", "SKIN DISEASE", "NEUROTIC DISORDER", "PRURITUS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "ZAFIRLUKAST", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL603", "mechanisms": ["Cysteinyl leukotriene receptor 1 antagonist"], "genes": ["CYSLTR1"], "type": "Small molecule", "diseases": ["ASTHMA", "OBSTRUCTIVE LUNG DISEASE", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}], "max_phase": 4, "name": "CETIRIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201113", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "URTICARIA"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "KIDNEY STONE", "stage": 3}], "max_phase": 4, "name": "ALFUZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1723", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["KIDNEY STONE", "BENIGN PROSTATIC HYPERPLASIA"]}, {"indications": [{"efo_term": "CATARACT", "stage": 3}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 1}], "max_phase": 4, "name": "PHENYLEPHRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200339", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["CATARACT", "CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 1}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "DIPHENHYDRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1620", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY", "ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}, {"efo_term": "ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "FEXOFENADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200618", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "LEVOCETIRIZINE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201190", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["FISH-EYE DISEASE", "URTICARIA"]}, {"indications": [{"efo_term": "EYE ALLERGY", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}], "max_phase": 4, "name": "ALCAFTADINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201747", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["EYE ALLERGY", "ALLERGIC CONJUNCTIVITIS"]}, {"indications": [{"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "BEPOTASTINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201759", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC CONJUNCTIVITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "TEDATIOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104986", "mechanisms": ["Alpha-1a adrenergic receptor antagonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "MIDODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200461", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["STROKE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PHENYLEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062264", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RAUWOLFIA SERPENTINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3559672", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 4}], "max_phase": 4, "name": "ASTEMIZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 4}], "max_phase": 4, "name": "ACRIVASTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1224", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "CHLORPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1659", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}], "max_phase": 4, "name": "CYPROHEPTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1716", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 1}], "max_phase": 4, "name": "PROMETHAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200750", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "LEVOCABASTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237102", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "ESMIRTAZAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107339", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 1}], "max_phase": 2, "name": "LY2624803", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545287", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [], "max_phase": 2, "name": "DABUZALGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL257978", "mechanisms": ["Alpha-1a adrenergic receptor partial agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200695", "mechanisms": ["Alpha-1a adrenergic receptor agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DAPIPRAZOLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201044", "mechanisms": ["Alpha-1a adrenergic receptor antagonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201535", "mechanisms": ["Alpha-1a adrenergic receptor agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRAZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1558", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXAZOSIN MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200561", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Adrenergic receptor alpha-1 antagonist", "Histamine H1 receptor antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D", "HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TERAZOSIN HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201091", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHOXAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201103", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METARAMINOL BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062262", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Adrenergic receptor alpha antagonist", "Histamine H1 receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D", "HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NAPHAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1706", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRAHYDROZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200413", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENOXYBENZAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200787", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENTOLAMINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200873", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALSEROXYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201454", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ERGOTAMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062265", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CR-3465", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545273", "mechanisms": ["Cysteinyl leukotriene receptor 1 antagonist"], "genes": ["CYSLTR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENYLPYRALINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1564", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1653", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VAPITADINE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL539843", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXYLAMINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200392", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUCLIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200403", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIMENHYDRINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200406", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIPELENNAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200446", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIPROLIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200450", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINASTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200491", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CYCLIZINE LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200497", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHDILAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200532", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANTAZOLINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200550", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MECLIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200590", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXBROMPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200638", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIPELENNAMINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200769", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CLEMASTINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200795", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HISTAMINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200801", "mechanisms": ["Histamine H1 receptor agonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXCHLORPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200927", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHDILAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200959", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BROMPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200961", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BROMODIPHENHYDRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200967", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARBINOXAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200974", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PYRILAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201006", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201007", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPIOMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201068", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENHYDRAMINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201089", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPHENIRAMINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201659", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMEPRAZINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713082", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EMEDASTINE DIFUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103739", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AZATADINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544908", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000120907", "label": "ADRA1A"}, {"assoc": 1.0, "id": "ENSG00000170214", "label": "ADRA1B"}, {"assoc": 1.0, "id": "ENSG00000171873", "label": "ADRA1D"}, {"assoc": 1.0, "id": "ENSG00000173198", "label": "CYSLTR1"}, {"assoc": 1.0, "id": "ENSG00000196639", "label": "HRH1"}], "size": 5}, {"diseases": [], "links": [{"source": "ENSG00000013725", "target": "ENSG00000110448"}, {"source": "ENSG00000013725", "target": "ENSG00000170017"}], "drugs": [{"indications": [], "max_phase": 2, "name": "ONCOLYSIN CD6", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109485", "mechanisms": ["T-cell differentiation antigen CD6 binding agent"], "genes": ["CD6"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ZOLIMOMAB ARITOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108785", "mechanisms": ["T-cell surface glycoprotein CD5 binding agent"], "genes": ["CD5"], "type": "Antibody", "diseases": []}], "heat": 0.3709279135256, "nodes": [{"assoc": 0.639082520805, "id": "ENSG00000013725", "label": "CD6"}, {"assoc": 0.426379566994, "id": "ENSG00000110448", "label": "CD5"}, {"assoc": 0.0473216527778, "id": "ENSG00000170017", "label": "ALCAM"}], "size": 3}, {"diseases": ["BASAL CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PSORIASIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SEPSIS", "BREAST CARCINOMA", "ATOPIC ECZEMA", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "HYPOPARATHYROIDISM", "HYPOCALCEMIA", "OSTEOPOROSIS", "PROSTATE CARCINOMA", "HYPERTENSION", "MENOPAUSE", "ACUTE KIDNEY INJURY", "HEART FAILURE", "HEPATITIS C INFECTION", "NEUROFIBROMATOSIS TYPE 1", "SICKLE CELL ANEMIA", "TIBIA FRACTURE", "TYPE II DIABETES MELLITUS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "COLORECTAL ADENOCARCINOMA", "MULTIPLE SCLEROSIS", "VITAMIN D DEFICIENCY", "ABNORMAL GLUCOSE TOLERANCE", "CROHN'S DISEASE", "INFLUENZA INFECTION", "COLORECTAL ADENOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "OBESITY", "INFECTION", "COGNITIVE IMPAIRMENT", "TUBERCULOSIS", "DIABETES MELLITUS", "HYPOGONADISM", "ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "AIDS", "SKIN NEOPLASM", "METABOLIC SYNDROME", "PROSTATE ADENOCARCINOMA", "IRRITABLE BOWEL SYNDROME", "NON-ALCOHOLIC FATTY LIVER DISEASE", "ALLERGIC CONJUNCTIVITIS", "ALLERGY", "PREGNANCY", "POSTMENOPAUSAL OSTEOPOROSIS", "PARKINSON'S DISEASE", "AUTISM", "AGING", "HYPERLIPIDEMIA", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "PREMATURE BIRTH", "OPTIC NEURITIS", "MELANOMA", "RESPIRATORY TRACT INFECTION", "CARDIOVASCULAR DISEASE", "NEOPLASM", "BONE FRACTURE", "APHTHOUS ULCER", "BLADDER CARCINOMA", "INFLAMMATORY BOWEL DISEASE", "HYPERPARATHYROIDISM", "LUNG CARCINOMA", "OSTEOPENIA", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "OSTEOARTHRITIS", "ULCERATIVE COLITIS", "SARCOPENIA", "CANCER", "POLYCYSTIC OVARY SYNDROME", "RESTLESS LEGS SYNDROME", "CYSTIC FIBROSIS", "INSULIN RESISTANCE", "CUTANEOUS LUPUS ERYTHEMATOSUS", "SECONDARY HYPERPARATHYROIDISM", "IGA GLOMERULONEPHRITIS", "PROTEINURIA", "ACNE", "SYSTEMIC SCLERODERMA", "ACUTE MYELOID LEUKEMIA", "MYOCARDIAL INFARCTION"], "links": [{"source": "ENSG00000019186", "target": "ENSG00000111012"}, {"source": "ENSG00000019186", "target": "ENSG00000111424"}], "drugs": [{"indications": [{"efo_term": "VITAMIN D DEFICIENCY", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "INFLUENZA INFECTION", "stage": 3}, {"efo_term": "COLORECTAL ADENOMA", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "INFECTION", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "HYPOGONADISM", "stage": 3}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "RESPIRATORY TRACT INFECTION", "stage": 3}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ABNORMAL GLUCOSE TOLERANCE", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "AIDS", "stage": 2}, {"efo_term": "METABOLIC SYNDROME", "stage": 2}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 2}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "ALLERGY", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "AGING", "stage": 2}, {"efo_term": "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 1}, {"efo_term": "TIBIA FRACTURE", "stage": 1}, {"efo_term": "PNEUMONIA", "stage": 1}, {"efo_term": "SKIN NEOPLASM", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 1}, {"efo_term": "HYPERLIPIDEMIA", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 0}], "max_phase": 4, "name": "CHOLECALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1042", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "HEART FAILURE", "HEPATITIS C INFECTION", "NEUROFIBROMATOSIS TYPE 1", "SICKLE CELL ANEMIA", "SYSTEMIC LUPUS ERYTHEMATOSUS", "TIBIA FRACTURE", "TYPE II DIABETES MELLITUS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "COLORECTAL ADENOCARCINOMA", "MULTIPLE SCLEROSIS", "VITAMIN D DEFICIENCY", "ABNORMAL GLUCOSE TOLERANCE", "CROHN'S DISEASE", "INFLUENZA INFECTION", "COLORECTAL ADENOMA", "PROSTATE CARCINOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "OBESITY", "INFECTION", "COGNITIVE IMPAIRMENT", "TUBERCULOSIS", "DIABETES MELLITUS", "OSTEOPOROSIS", "HYPOGONADISM", "ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "AIDS", "SKIN NEOPLASM", "METABOLIC SYNDROME", "PROSTATE ADENOCARCINOMA", "TYPE I DIABETES MELLITUS", "IRRITABLE BOWEL SYNDROME", "NON-ALCOHOLIC FATTY LIVER DISEASE", "ALLERGIC CONJUNCTIVITIS", "ATOPIC ECZEMA", "ALLERGY", "PREGNANCY", "POSTMENOPAUSAL OSTEOPOROSIS", "PARKINSON'S DISEASE", "AUTISM", "AGING", "HYPERLIPIDEMIA", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "PREMATURE BIRTH", "OPTIC NEURITIS", "MELANOMA", "RESPIRATORY TRACT INFECTION", "CARDIOVASCULAR DISEASE", "NEOPLASM", "BONE FRACTURE"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "APHTHOUS ULCER", "stage": 3}, {"efo_term": "VITAMIN D DEFICIENCY", "stage": 3}, {"efo_term": "BLADDER CARCINOMA", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 3}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}, {"efo_term": "CYSTIC FIBROSIS", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "CUTANEOUS LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 1}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}, {"efo_term": "INFLAMMATORY BOWEL DISEASE", "stage": 1}, {"efo_term": "HYPERPARATHYROIDISM", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}, {"efo_term": "ULCERATIVE COLITIS", "stage": 1}, {"efo_term": "SARCOPENIA", "stage": 1}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 1}, {"efo_term": "OSTEOPENIA", "stage": 0}], "max_phase": 4, "name": "ERGOCALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1536", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "BREAST NEOPLASM", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "APHTHOUS ULCER", "VITAMIN D DEFICIENCY", "BLADDER CARCINOMA", "TYPE I DIABETES MELLITUS", "BREAST CARCINOMA", "COLORECTAL ADENOCARCINOMA", "TYPE II DIABETES MELLITUS", "INFLAMMATORY BOWEL DISEASE", "MULTIPLE SCLEROSIS", "HYPERPARATHYROIDISM", "LUNG CARCINOMA", "OSTEOPENIA", "PROSTATE ADENOCARCINOMA", "OBESITY", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "HIV INFECTION", "NON-ALCOHOLIC FATTY LIVER DISEASE", "HEART FAILURE", "OSTEOARTHRITIS", "SICKLE CELL ANEMIA", "ULCERATIVE COLITIS", "SARCOPENIA", "TUBERCULOSIS", "CANCER", "POLYCYSTIC OVARY SYNDROME", "PREGNANCY", "RESTLESS LEGS SYNDROME", "OPTIC NEURITIS", "CYSTIC FIBROSIS", "INSULIN RESISTANCE", "CUTANEOUS LUPUS ERYTHEMATOSUS", "ASTHMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "HYPOPARATHYROIDISM", "stage": 4}, {"efo_term": "HYPOCALCEMIA", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 3}, {"efo_term": "BASAL CELL CARCINOMA", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}, {"efo_term": "MENOPAUSE", "stage": 1}], "max_phase": 4, "name": "CALCITRIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["BASAL CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PSORIASIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SEPSIS", "BREAST CARCINOMA", "ATOPIC ECZEMA", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "HYPOPARATHYROIDISM", "HYPOCALCEMIA", "OSTEOPOROSIS", "PROSTATE CARCINOMA", "HYPERTENSION", "MENOPAUSE", "ACUTE KIDNEY INJURY"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 4}, {"efo_term": "SECONDARY HYPERPARATHYROIDISM", "stage": 4}, {"efo_term": "IGA GLOMERULONEPHRITIS", "stage": 3}, {"efo_term": "PROTEINURIA", "stage": 3}, {"efo_term": "HYPERPARATHYROIDISM", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "ALLERGY", "stage": 2}], "max_phase": 4, "name": "PARICALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200622", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "IGA GLOMERULONEPHRITIS", "PROTEINURIA", "TYPE II DIABETES MELLITUS", "SECONDARY HYPERPARATHYROIDISM", "HYPERPARATHYROIDISM", "ALLERGY"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 1}], "max_phase": 4, "name": "CALCIPOTRIENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200666", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS", "ACNE", "SYSTEMIC SCLERODERMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "DOXERCALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200810", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS", "NEOPLASM", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "SECONDARY HYPERPARATHYROIDISM", "stage": 2}, {"efo_term": "OSTEOPOROSIS", "stage": 2}], "max_phase": 2, "name": "DP001", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605525", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["SECONDARY HYPERPARATHYROIDISM", "OSTEOPOROSIS"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 3}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}], "max_phase": 4, "name": "CALCIFEDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544909", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["MYOCARDIAL INFARCTION", "ACUTE KIDNEY INJURY"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 2, "name": "BECOCALCIDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104955", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}], "max_phase": 2, "name": "INECALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105107", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 3}], "max_phase": 3, "name": "PEFCALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137307", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [], "max_phase": 1, "name": "ILX23-7553", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284121", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "SEOCALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908376", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "LUNACALCIPOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105705", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Elocalcitol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545094", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}], "heat": 0.7062907906286666, "nodes": [{"assoc": 0.62449727265, "id": "ENSG00000019186", "label": "CYP24A1"}, {"assoc": 0.494375099236, "id": "ENSG00000111012", "label": "CYP27B1"}, {"assoc": 1.0, "id": "ENSG00000111424", "label": "VDR"}], "size": 3}, {"diseases": ["RHEUMATIC DISEASE", "OSTEOARTHRITIS", "PAIN", "HIV INFECTION", "DYSMENORRHEA", "OSTEOARTHRITIS, HIP", "RHEUMATOID ARTHRITIS", "TUBERCULOSIS", "ANKYLOSING SPONDYLITIS", "OSTEOARTHRITIS, KNEE", "BREAST CARCINOMA", "CHRONIC CHILDHOOD ARTHRITIS", "LUNG CARCINOMA", "TONSILLITIS", "CENTRAL NERVOUS SYSTEM CANCER", "FAMILIAL ADENOMATOUS POLYPOSIS", "PREECLAMPSIA", "COLORECTAL ADENOCARCINOMA", "GOUT", "SCHIZOPHRENIA", "NON-SMALL CELL LUNG CARCINOMA", "MOUTH NEOPLASM", "OBESITY", "BLADDER CARCINOMA", "PROSTATE CARCINOMA", "NEOPLASM", "CERVICAL ADENOCARCINOMA", "NASOPHARYNGEAL NEOPLASM", "HYPERTENSION", "LYMPHANGIOLEIOMYOMATOSIS", "COLORECTAL ADENOMA", "UNIPOLAR DEPRESSION", "NICOTINE DEPENDENCE", "INFLAMMATION", "PROSTATE ADENOCARCINOMA", "HEMORRHAGE", "POLYP", "FISH-EYE DISEASE", "PANCREATITIS", "PANCREATIC CARCINOMA", "DIGESTIVE SYSTEM DISEASE", "PREMATURE BIRTH", "EYE INFLAMMATION", "ARTHRALGIA", "PATENT DUCTUS ARTERIOSUS", "MYALGIA", "CARDIOVASCULAR DISEASE", "ASTHMA", "RENAL COLIC", "NEUROPATHY", "ATRIAL FIBRILLATION", "BRAIN INFARCTION", "CORONARY ARTERY DISEASE", "DUODENAL ULCER", "FEVER", "PEPTIC ULCER", "PERIPHERAL ARTERIAL DISEASE", "TYPE II DIABETES MELLITUS", "INFECTIOUS MENINGITIS", "INFERTILITY", "MIGRAINE DISORDER", "STROKE", "SEPSIS", "SQUAMOUS CELL CARCINOMA", "PSYCHOSIS", "HEART FAILURE", "PULMONARY HYPERTENSION", "ACUTE LUNG INJURY", "GLIOBLASTOMA MULTIFORME", "HIV-1 INFECTION", "SICKLE CELL ANEMIA", "SKIN ULCER", "ATHEROSCLEROSIS", "BIPOLAR DISORDER", "VENOUS THROMBOEMBOLISM", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME", "RECURRENT THROMBOPHLEBITIS", "BREAST NEOPLASM", "OSTEOMYELITIS", "ESOPHAGEAL CARCINOMA", "PNEUMONIA", "CHRONIC KIDNEY DISEASE", "ISCHEMIA", "VENOUS THROMBOSIS", "DIABETES MELLITUS", "HYPERTROPHIC CARDIOMYOPATHY", "POLYCYTHEMIA VERA", "CORONARY HEART DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SEASONAL ALLERGIC RHINITIS", "BARRETT'S ESOPHAGUS", "VASCULAR DISEASE", "MYOCARDIAL INFARCTION", "HABITUAL ABORTION", "LYNCH SYNDROME", "PREGNANCY", "RETINAL VEIN OCCLUSION", "DIABETIC FOOT", "CEREBRAL ISCHEMIA", "ALZHEIMERS DISEASE", "OBSTRUCTIVE SLEEP APNEA", "ALLERGIC RHINITIS", "BRONCHOPULMONARY DYSPLASIA", "EMPHYSEMA", "BONE FRACTURE", "INFECTION", "VAGINAL INFLAMMATION", "DUCHENNE MUSCULAR DYSTROPHY", "COMMON COLD", "SPONDYLOARTHROPATHY", "BRAIN DISEASE", "RETINOPATHY OF PREMATURITY", "PERIODONTITIS", "CEREBRAL PALSY", "ARTHRITIS", "CLEFT PALATE", "INFLUENZA INFECTION", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "INJURY", "ABDOMINAL PAIN", "BACTERIAL MENINGITIS", "GLAUCOMA", "PULPITIS", "TYPE I DIABETES MELLITUS", "POST OPERATIVE NAUSEA AND VOMITING", "BASAL CELL CARCINOMA", "DIABETIC RETINOPATHY", "PULMONARY EMBOLISM", "COLITIS", "COLONIC DIVERTICULOSIS", "CROHN'S DISEASE", "PROCTITIS", "ULCERATIVE COLITIS", "IRRITABLE BOWEL SYNDROME", "NUTRITIONAL DISORDER", "BERYLLIOSIS", "CATARACT", "TIBIAL MUSCULAR DYSTROPHY", "PLEURAL EFFUSION", "GASTRIC ULCER", "MACULAR EDEMA", "ACTINIC KERATOSIS", "MUSCULAR DISEASE", "SKIN NEOPLASM", "TENDINOPATHY", "FROZEN SHOULDER", "LIVER DISEASE"], "links": [{"source": "ENSG00000073756", "target": "ENSG00000157870"}, {"source": "ENSG00000095303", "target": "ENSG00000157870"}], "drugs": [{"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "STROKE", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "RECURRENT THROMBOPHLEBITIS", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "BRAIN INFARCTION", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "PEPTIC ULCER", "stage": 3}, {"efo_term": "PERIPHERAL ARTERIAL DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "SKIN ULCER", "stage": 3}, {"efo_term": "ATHEROSCLEROSIS", "stage": 3}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "VENOUS THROMBOSIS", "stage": 3}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 3}, {"efo_term": "HYPERTROPHIC CARDIOMYOPATHY", "stage": 3}, {"efo_term": "CORONARY HEART DISEASE", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 3}, {"efo_term": "VASCULAR DISEASE", "stage": 3}, {"efo_term": "HABITUAL ABORTION", "stage": 3}, {"efo_term": "LYNCH SYNDROME", "stage": 3}, {"efo_term": "RETINAL VEIN OCCLUSION", "stage": 3}, {"efo_term": "DIABETIC FOOT", "stage": 3}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 3}, {"efo_term": "DUODENAL ULCER", "stage": 2}, {"efo_term": "INFECTIOUS MENINGITIS", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE LUNG INJURY", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "HIV-1 INFECTION", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "VENOUS THROMBOEMBOLISM", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "OSTEOMYELITIS", "stage": 2}, {"efo_term": "PNEUMONIA", "stage": 2}, {"efo_term": "ISCHEMIA", "stage": 2}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BARRETT'S ESOPHAGUS", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "PREGNANCY", "stage": 2}, {"efo_term": "COLORECTAL ADENOMA", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 1}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 1}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 0}], "max_phase": 4, "name": "ASPIRIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION", "BRAIN INFARCTION", "CORONARY ARTERY DISEASE", "DUODENAL ULCER", "FEVER", "PEPTIC ULCER", "PERIPHERAL ARTERIAL DISEASE", "TYPE II DIABETES MELLITUS", "INFECTIOUS MENINGITIS", "INFERTILITY", "MIGRAINE DISORDER", "STROKE", "PAIN", "PREECLAMPSIA", "SEPSIS", "SQUAMOUS CELL CARCINOMA", "CARDIOVASCULAR DISEASE", "PSYCHOSIS", "BREAST CARCINOMA", "HEART FAILURE", "PULMONARY HYPERTENSION", "ACUTE LUNG INJURY", "COLORECTAL ADENOCARCINOMA", "GLIOBLASTOMA MULTIFORME", "HIV INFECTION", "HIV-1 INFECTION", "SICKLE CELL ANEMIA", "SKIN ULCER", "ATHEROSCLEROSIS", "BIPOLAR DISORDER", "VENOUS THROMBOEMBOLISM", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME", "RECURRENT THROMBOPHLEBITIS", "BREAST NEOPLASM", "OSTEOMYELITIS", "ESOPHAGEAL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PNEUMONIA", "CHRONIC KIDNEY DISEASE", "ISCHEMIA", "VENOUS THROMBOSIS", "ASTHMA", "DIABETES MELLITUS", "HYPERTROPHIC CARDIOMYOPATHY", "POLYCYTHEMIA VERA", "NEOPLASM", "CORONARY HEART DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SEASONAL ALLERGIC RHINITIS", "BARRETT'S ESOPHAGUS", "VASCULAR DISEASE", "MYOCARDIAL INFARCTION", "HABITUAL ABORTION", "DIGESTIVE SYSTEM DISEASE", "LYNCH SYNDROME", "PREGNANCY", "RETINAL VEIN OCCLUSION", "DIABETIC FOOT", "COLORECTAL ADENOMA", "CEREBRAL ISCHEMIA", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "FAMILIAL ADENOMATOUS POLYPOSIS", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "DYSMENORRHEA", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "GOUT", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "COLORECTAL ADENOMA", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "TONSILLITIS", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "PREECLAMPSIA", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "LYMPHANGIOLEIOMYOMATOSIS", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "MOUTH NEOPLASM", "stage": 1}, {"efo_term": "CERVICAL ADENOCARCINOMA", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}, {"efo_term": "OBESITY", "stage": 0}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 0}], "max_phase": 4, "name": "CELECOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["ANKYLOSING SPONDYLITIS", "BREAST CARCINOMA", "CHRONIC CHILDHOOD ARTHRITIS", "LUNG CARCINOMA", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "RHEUMATOID ARTHRITIS", "TONSILLITIS", "CENTRAL NERVOUS SYSTEM CANCER", "FAMILIAL ADENOMATOUS POLYPOSIS", "PREECLAMPSIA", "COLORECTAL ADENOCARCINOMA", "GOUT", "SCHIZOPHRENIA", "NON-SMALL CELL LUNG CARCINOMA", "MOUTH NEOPLASM", "OBESITY", "BLADDER CARCINOMA", "PROSTATE CARCINOMA", "NEOPLASM", "RHEUMATIC DISEASE", "DYSMENORRHEA", "CERVICAL ADENOCARCINOMA", "NASOPHARYNGEAL NEOPLASM", "HYPERTENSION", "LYMPHANGIOLEIOMYOMATOSIS", "COLORECTAL ADENOMA", "UNIPOLAR DEPRESSION", "NICOTINE DEPENDENCE", "INFLAMMATION", "PROSTATE ADENOCARCINOMA"]}, {"indications": [{"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "VAGINAL INFLAMMATION", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "FEVER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 3}, {"efo_term": "INFECTION", "stage": 3}, {"efo_term": "PEPTIC ULCER", "stage": 3}, {"efo_term": "COMMON COLD", "stage": 3}, {"efo_term": "CEREBRAL PALSY", "stage": 3}, {"efo_term": "BRONCHOPULMONARY DYSPLASIA", "stage": 2}, {"efo_term": "EMPHYSEMA", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "SPONDYLOARTHROPATHY", "stage": 2}, {"efo_term": "BRAIN DISEASE", "stage": 2}, {"efo_term": "HEMORRHAGE", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "PREGNANCY", "stage": 2}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 2}, {"efo_term": "PERIODONTITIS", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 1}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "IBUPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL521", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["FEVER", "MYALGIA", "OSTEOARTHRITIS", "PAIN", "PATENT DUCTUS ARTERIOSUS", "ALZHEIMERS DISEASE", "OBSTRUCTIVE SLEEP APNEA", "OSTEOARTHRITIS, KNEE", "ALLERGIC RHINITIS", "BRONCHOPULMONARY DYSPLASIA", "EMPHYSEMA", "ARTHRALGIA", "BONE FRACTURE", "DYSMENORRHEA", "HYPERTENSION", "INFECTION", "VAGINAL INFLAMMATION", "DUCHENNE MUSCULAR DYSTROPHY", "PEPTIC ULCER", "COMMON COLD", "RHEUMATIC DISEASE", "CARDIOVASCULAR DISEASE", "SPONDYLOARTHROPATHY", "BRAIN DISEASE", "HEMORRHAGE", "UNIPOLAR DEPRESSION", "PREGNANCY", "RETINOPATHY OF PREMATURITY", "TUBERCULOSIS", "PERIODONTITIS", "CEREBRAL PALSY"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "DYSMENORRHEA", "stage": 4}, {"efo_term": "COMMON COLD", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "ABDOMINAL PAIN", "stage": 3}, {"efo_term": "BACTERIAL MENINGITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 2}, {"efo_term": "CLEFT PALATE", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "HEMORRHAGE", "stage": 2}, {"efo_term": "CERVICAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "TONSILLITIS", "stage": 2}, {"efo_term": "BRAIN DISEASE", "stage": 2}, {"efo_term": "PULPITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "RENAL COLIC", "stage": 2}, {"efo_term": "GLAUCOMA", "stage": 0}], "max_phase": 4, "name": "ACETAMINOPHEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["FEVER", "MIGRAINE DISORDER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "DIGESTIVE SYSTEM DISEASE", "ARTHRITIS", "CLEFT PALATE", "PATENT DUCTUS ARTERIOSUS", "HYPERTENSION", "INFLUENZA INFECTION", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "SEPSIS", "INJURY", "ABDOMINAL PAIN", "DYSMENORRHEA", "COMMON COLD", "HEMORRHAGE", "BACTERIAL MENINGITIS", "CERVICAL ADENOCARCINOMA", "GLAUCOMA", "TONSILLITIS", "BRAIN DISEASE", "PULPITIS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS, HIP", "RENAL COLIC"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "VAGINAL INFLAMMATION", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "GASTRIC ULCER", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 3}, {"efo_term": "PEPTIC ULCER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "DUODENAL ULCER", "stage": 2}, {"efo_term": "PLEURAL EFFUSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "TIBIAL MUSCULAR DYSTROPHY", "stage": 1}, {"efo_term": "LYNCH SYNDROME", "stage": 1}], "max_phase": 4, "name": "NAPROXEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS", "PAIN", "ARTHRALGIA", "RHEUMATOID ARTHRITIS", "TIBIAL MUSCULAR DYSTROPHY", "LYNCH SYNDROME", "VAGINAL INFLAMMATION", "ANKYLOSING SPONDYLITIS", "MYALGIA", "OSTEOARTHRITIS, KNEE", "CHRONIC CHILDHOOD ARTHRITIS", "PEPTIC ULCER", "RHEUMATIC DISEASE", "DUODENAL ULCER", "PLEURAL EFFUSION", "ALZHEIMERS DISEASE", "GASTRIC ULCER", "OSTEOARTHRITIS, HIP"]}, {"indications": [{"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "GOUT", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "RENAL COLIC", "stage": 3}, {"efo_term": "PANCREATITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 0}], "max_phase": 4, "name": "INDOMETHACIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["DIGESTIVE SYSTEM DISEASE", "GOUT", "PANCREATITIS", "PREMATURE BIRTH", "ANKYLOSING SPONDYLITIS", "EYE INFLAMMATION", "ARTHRALGIA", "PAIN", "PATENT DUCTUS ARTERIOSUS", "FISH-EYE DISEASE", "MYALGIA", "CARDIOVASCULAR DISEASE", "RHEUMATIC DISEASE", "ASTHMA", "RENAL COLIC"]}, {"indications": [{"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "BASAL CELL CARCINOMA", "stage": 2}, {"efo_term": "PULMONARY EMBOLISM", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 1}], "max_phase": 4, "name": "DICLOFENAC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["EYE INFLAMMATION", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "ANKYLOSING SPONDYLITIS", "BASAL CELL CARCINOMA", "RHEUMATOID ARTHRITIS", "UNIPOLAR DEPRESSION", "ARTHRALGIA", "DIABETIC RETINOPATHY", "MYALGIA", "PULMONARY EMBOLISM", "RHEUMATIC DISEASE", "INFERTILITY", "OSTEOARTHRITIS, HIP"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 3}, {"efo_term": "PROCTITIS", "stage": 3}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 3}, {"efo_term": "COLITIS", "stage": 2}, {"efo_term": "COLONIC DIVERTICULOSIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOMA", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "LYNCH SYNDROME", "stage": 2}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 1}, {"efo_term": "BERYLLIOSIS", "stage": 1}], "max_phase": 4, "name": "MESALAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["COLITIS", "COLONIC DIVERTICULOSIS", "CROHN'S DISEASE", "PROCTITIS", "ULCERATIVE COLITIS", "IRRITABLE BOWEL SYNDROME", "NUTRITIONAL DISORDER", "COLORECTAL ADENOMA", "BERYLLIOSIS", "COLORECTAL ADENOCARCINOMA", "LYNCH SYNDROME"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 1}], "max_phase": 4, "name": "ETORICOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416146", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "OSTEOARTHRITIS", "PAIN", "HIV INFECTION", "DYSMENORRHEA", "OSTEOARTHRITIS, HIP", "RHEUMATOID ARTHRITIS", "TUBERCULOSIS", "ANKYLOSING SPONDYLITIS", "OSTEOARTHRITIS, KNEE"]}, {"indications": [{"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 3}, {"efo_term": "PERIODONTITIS", "stage": 2}, {"efo_term": "RENAL COLIC", "stage": 1}], "max_phase": 4, "name": "KETOPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL571", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["MYALGIA", "OSTEOARTHRITIS", "ARTHRALGIA", "MIGRAINE DISORDER", "OSTEOARTHRITIS, KNEE", "PAIN", "RHEUMATIC DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "RENAL COLIC", "PERIODONTITIS"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ACTINIC KERATOSIS", "stage": 3}, {"efo_term": "MUSCULAR DISEASE", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "SKIN NEOPLASM", "stage": 2}, {"efo_term": "GOUT", "stage": 2}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "DICLOFENAC SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1034", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["ACTINIC KERATOSIS", "MUSCULAR DISEASE", "OSTEOARTHRITIS", "PAIN", "OSTEOARTHRITIS, KNEE", "SKIN NEOPLASM", "RHEUMATOID ARTHRITIS", "INFLAMMATION", "GOUT"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "HEMORRHAGE", "stage": 1}], "max_phase": 4, "name": "MELOXICAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL599", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS", "PAIN", "DYSMENORRHEA", "ANKYLOSING SPONDYLITIS", "TUBERCULOSIS", "RHEUMATIC DISEASE", "RHEUMATOID ARTHRITIS", "HEMORRHAGE"]}, {"indications": [{"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "RENAL COLIC", "stage": 1}], "max_phase": 4, "name": "PIROXICAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL527", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "ARTHRALGIA", "EYE INFLAMMATION", "MYALGIA", "RHEUMATOID ARTHRITIS", "OSTEOARTHRITIS", "RHEUMATIC DISEASE", "RENAL COLIC"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "DYSMENORRHEA", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "GOUT", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}], "max_phase": 4, "name": "NAPROXEN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200806", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS", "PAIN", "RHEUMATOID ARTHRITIS", "DYSMENORRHEA", "ANKYLOSING SPONDYLITIS", "TENDINOPATHY", "GOUT", "FROZEN SHOULDER"]}, {"indications": [{"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "PERIODONTITIS", "stage": 2}], "max_phase": 4, "name": "FLURBIPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["EYE INFLAMMATION", "MYALGIA", "PAIN", "ARTHRALGIA", "PERIODONTITIS", "RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "CATARACT", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PULPITIS", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "KETOROLAC TROMETHAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201124", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "PAIN", "CATARACT", "ALLERGIC RHINITIS", "BREAST CARCINOMA", "PULPITIS"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "ETODOLAC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL622", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "PAIN", "FISH-EYE DISEASE", "OSTEOARTHRITIS", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "POLYP", "stage": 2}], "max_phase": 4, "name": "ROFECOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "POLYP", "OSTEOARTHRITIS", "RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "PANCREATITIS", "stage": 2}], "max_phase": 4, "name": "VALDECOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["PAIN", "OSTEOARTHRITIS", "RHEUMATIC DISEASE", "PANCREATITIS"]}, {"indications": [{"efo_term": "CATARACT", "stage": 4}, {"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "MACULAR EDEMA", "stage": 2}], "max_phase": 4, "name": "NEPAFENAC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1021", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "CATARACT", "EYE INFLAMMATION", "MACULAR EDEMA"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}], "max_phase": 4, "name": "OXYPHENBUTAZONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1228", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "EYE INFLAMMATION", "MYALGIA", "ARTHRALGIA"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "NAPROXCINOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103831", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "LIVER DISEASE", "OSTEOARTHRITIS", "OSTEOARTHRITIS, HIP"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}], "max_phase": 4, "name": "PHENYLBUTAZONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL101", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "MYALGIA", "ARTHRALGIA"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 2}], "max_phase": 4, "name": "MEFENAMIC ACID", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "DYSMENORRHEA", "HEMORRHAGE"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 2}], "max_phase": 4, "name": "DICLOFENAC POTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200804", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["PAIN", "DYSMENORRHEA", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}], "max_phase": 3, "name": "POLMACOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL166863", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, HIP", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}], "max_phase": 2, "name": "APRICOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1835207", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["PANCREATIC CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "NEUROPATHY", "stage": 2}], "max_phase": 4, "name": "SULFASALAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["ANKYLOSING SPONDYLITIS", "NEUROPATHY"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}], "max_phase": 4, "name": "SULINDAC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15770", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "COLORECTAL ADENOCARCINOMA"]}, {"indications": [{"efo_term": "CATARACT", "stage": 2}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "BROMFENAC SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL751", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["CATARACT", "INFLAMMATION"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "DIFLUNISAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL898", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["FEVER", "PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 0}], "max_phase": 4, "name": "DICLOFENAC EPOLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201180", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["PAIN", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}], "max_phase": 4, "name": "NABUMETONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1070", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}], "max_phase": 4, "name": "SUPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL956", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}], "max_phase": 4, "name": "OXAPROZIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1071", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "INDOMETHACIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200864", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["INFLAMMATION"]}, {"indications": [{"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 4}], "max_phase": 4, "name": "IBUPROFEN LYSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201141", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["PATENT DUCTUS ARTERIOSUS"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "IBUPROFEN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1241153", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 2}], "max_phase": 2, "name": "NAPROXEN ETEMESIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105683", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS"]}, {"indications": [], "max_phase": 4, "name": "CARPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1316", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MECLOFENAMATE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL876", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BISMUTH SUBSALICYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1120", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXAPROZIN POTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200463", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMINOSALICYLATE POTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200584", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLMETIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200613", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BALSALAZIDE DISODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200760", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLURBIPROFEN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200990", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OLSALAZINE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201013", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMINOSALICYLATE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096646", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FENOPROFEN CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103736", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}], "heat": 0.7466666666666667, "nodes": [{"assoc": 1.0, "id": "ENSG00000073756", "label": "PTGS2"}, {"assoc": 1.0, "id": "ENSG00000095303", "label": "PTGS1"}, {"assoc": 0.24, "id": "ENSG00000157870", "label": "FAM213B"}], "size": 3}, {"diseases": ["RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS", "PSORIASIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA", "CANCER", "LIVER DISEASE", "DIABETIC NEPHROPATHY", "PULMONARY HYPERTENSION"], "links": [{"source": "ENSG00000079999", "target": "ENSG00000102763"}, {"source": "ENSG00000079999", "target": "ENSG00000103495"}], "drugs": [{"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "DIMETHYL FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107333", "mechanisms": ["Kelch-like ECH-associated protein 1 inhibitor"], "genes": ["KEAP1"], "type": "Small molecule", "diseases": ["RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS", "PSORIASIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "BARDOXOLONE METHYL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1762621", "mechanisms": ["Keap1/Nrf2 inhibitor"], "genes": ["KEAP1"], "type": "Small molecule", "diseases": ["CANCER", "LIVER DISEASE", "DIABETIC NEPHROPATHY", "PULMONARY HYPERTENSION"]}], "heat": 0.4963207444666667, "nodes": [{"assoc": 1.0, "id": "ENSG00000079999", "label": "KEAP1"}, {"assoc": 0.2159176003, "id": "ENSG00000102763", "label": "VWA8"}, {"assoc": 0.2730446331, "id": "ENSG00000103495", "label": "MAZ"}], "size": 3}, {"diseases": ["NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "PSORIATIC ARTHRITIS", "ACUTE GRAFT VS. HOST DISEASE", "CANCER", "CHRONIC FATIGUE SYNDROME", "HODGKINS LYMPHOMA", "LYMPHOMA", "MEMBRANOUS GLOMERULONEPHRITIS", "NEOPLASM OF MATURE B-CELLS", "RHEUMATOID ARTHRITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SYSTEMIC SCLERODERMA", "MALT LYMPHOMA", "METASTATIC MELANOMA", "MULTIPLE SCLEROSIS", "PROSTATE CARCINOMA", "WEGENER'S GRANULOMATOSIS", "DIFFUSE LARGE B-CELL LYMPHOMA", "HEMOPHILIA A", "KIDNEY DISEASE", "MYASTHENIA GRAVIS", "ACUTE LYMPHOBLASTIC LEUKEMIA", "LYMPHOPROLIFERATIVE DISORDER", "NEUROMYELITIS OPTICA", "SJOGREN SYNDROME", "MACROGLOBULINEMIA", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "NEPHROTIC SYNDROME", "NEUROPATHY", "ULCERATIVE COLITIS", "BEHCET'S SYNDROME", "LEUKEMIA", "TYPE I DIABETES MELLITUS", "SARCOIDOSIS", "MANTLE CELL LYMPHOMA", "NEOPLASM", "MICROSCOPIC POLYANGIITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "ALVEOLAR PROTEINOSIS", "CHRONIC KIDNEY DISEASE", "AUTOIMMUNE THROMBOCYTOPENIC PURPURA", "PEMPHIGUS VULGARIS", "AGE-RELATED MACULAR DEGENERATION", "PROTEINURIA", "SCLERITIS", "BULLOUS PEMPHIGOID", "PERIPHERAL NEUROPATHY", "GRAVES OPHTHALMOPATHY", "MELANOMA", "IMMUNE SYSTEM DISEASE"], "links": [{"source": "ENSG00000101017", "target": "ENSG00000156738"}, {"source": "ENSG00000156738", "target": "ENSG00000204287"}], "drugs": [{"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "WEGENER'S GRANULOMATOSIS", "stage": 4}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 4}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "MICROSCOPIC POLYANGIITIS", "stage": 4}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 3}, {"efo_term": "CHRONIC FATIGUE SYNDROME", "stage": 3}, {"efo_term": "HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 3}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 3}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "MALT LYMPHOMA", "stage": 3}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 3}, {"efo_term": "MYASTHENIA GRAVIS", "stage": 3}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "MANTLE CELL LYMPHOMA", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "AUTOIMMUNE THROMBOCYTOPENIC PURPURA", "stage": 3}, {"efo_term": "PEMPHIGUS VULGARIS", "stage": 3}, {"efo_term": "PROTEINURIA", "stage": 3}, {"efo_term": "BULLOUS PEMPHIGOID", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "MEMBRANOUS GLOMERULONEPHRITIS", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "HEMOPHILIA A", "stage": 2}, {"efo_term": "KIDNEY DISEASE", "stage": 2}, {"efo_term": "LYMPHOPROLIFERATIVE DISORDER", "stage": 2}, {"efo_term": "SJOGREN SYNDROME", "stage": 2}, {"efo_term": "MACROGLOBULINEMIA", "stage": 2}, {"efo_term": "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "BEHCET'S SYNDROME", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "ALVEOLAR PROTEINOSIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "METASTATIC MELANOMA", "stage": 1}, {"efo_term": "NEUROMYELITIS OPTICA", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 1}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 1}, {"efo_term": "SCLERITIS", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 0}], "max_phase": 4, "name": "RITUXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201576", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["ACUTE GRAFT VS. HOST DISEASE", "CANCER", "CHRONIC FATIGUE SYNDROME", "HODGKINS LYMPHOMA", "LYMPHOMA", "MEMBRANOUS GLOMERULONEPHRITIS", "NEOPLASM OF MATURE B-CELLS", "NON-HODGKINS LYMPHOMA", "RHEUMATOID ARTHRITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SYSTEMIC SCLERODERMA", "MALT LYMPHOMA", "METASTATIC MELANOMA", "MULTIPLE SCLEROSIS", "PROSTATE CARCINOMA", "WEGENER'S GRANULOMATOSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA", "DIFFUSE LARGE B-CELL LYMPHOMA", "HEMOPHILIA A", "KIDNEY DISEASE", "MYASTHENIA GRAVIS", "ACUTE LYMPHOBLASTIC LEUKEMIA", "LYMPHOPROLIFERATIVE DISORDER", "NEUROMYELITIS OPTICA", "SJOGREN SYNDROME", "MACROGLOBULINEMIA", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "NEPHROTIC SYNDROME", "NEUROPATHY", "ULCERATIVE COLITIS", "BEHCET'S SYNDROME", "LEUKEMIA", "TYPE I DIABETES MELLITUS", "SARCOIDOSIS", "MANTLE CELL LYMPHOMA", "NEOPLASM", "MICROSCOPIC POLYANGIITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "ALVEOLAR PROTEINOSIS", "CHRONIC KIDNEY DISEASE", "AUTOIMMUNE THROMBOCYTOPENIC PURPURA", "PEMPHIGUS VULGARIS", "AGE-RELATED MACULAR DEGENERATION", "PROTEINURIA", "SCLERITIS", "BULLOUS PEMPHIGOID", "PERIPHERAL NEUROPATHY", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "PEMPHIGUS VULGARIS", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}, {"efo_term": "HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "MANTLE CELL LYMPHOMA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}], "max_phase": 4, "name": "OFATUMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201836", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA", "LYMPHOMA", "LEUKEMIA", "RHEUMATOID ARTHRITIS", "DIFFUSE LARGE B-CELL LYMPHOMA", "MULTIPLE SCLEROSIS", "HODGKINS LYMPHOMA", "ACUTE GRAFT VS. HOST DISEASE", "NON-HODGKINS LYMPHOMA", "CANCER", "NEOPLASM", "MELANOMA", "NEPHROTIC SYNDROME", "NEOPLASM OF MATURE B-CELLS", "PEMPHIGUS VULGARIS", "MANTLE CELL LYMPHOMA"]}, {"indications": [{"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 1}], "max_phase": 4, "name": "OCRELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108041", "mechanisms": ["B-lymphocyte antigen CD20 other"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["RELAPSING-REMITTING MULTIPLE SCLEROSIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS", "NON-HODGKINS LYMPHOMA", "RHEUMATOID ARTHRITIS", "IMMUNE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}], "max_phase": 4, "name": "OBINUTUZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743048", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["CHRONIC LYMPHOCYTIC LEUKEMIA", "NON-HODGKINS LYMPHOMA", "NEOPLASM", "LYMPHOMA", "ACUTE GRAFT VS. HOST DISEASE"]}, {"indications": [{"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 2, "name": "DACETUZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743005", "mechanisms": ["Tumor necrosis factor receptor superfamily member 5 inhibitor"], "genes": ["CD40"], "type": "Antibody", "diseases": ["NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "NEUROMYELITIS OPTICA", "stage": 1}], "max_phase": 3, "name": "UBLITUXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108354", "mechanisms": ["B-lymphocyte antigen CD20 other"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["NEUROMYELITIS OPTICA", "MULTIPLE SCLEROSIS", "CHRONIC LYMPHOCYTIC LEUKEMIA"]}, {"indications": [{"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}], "max_phase": 4, "name": "TOSITUMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201604", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["NON-HODGKINS LYMPHOMA", "MULTIPLE MYELOMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "AUTOIMMUNE THROMBOCYTOPENIC PURPURA", "stage": 1}], "max_phase": 2, "name": "VELTUZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743088", "mechanisms": ["B-lymphocyte antigen CD20 inhibitor"], "genes": ["MS4A1"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "AUTOIMMUNE THROMBOCYTOPENIC PURPURA"]}, {"indications": [{"efo_term": "PSORIATIC ARTHRITIS", "stage": 1}], "max_phase": 2, "name": "PG-102", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109475", "mechanisms": ["Tumor necrosis factor receptor superfamily member 5 inhibitor"], "genes": ["CD40"], "type": "Antibody", "diseases": ["PSORIATIC ARTHRITIS"]}, {"indications": [], "max_phase": 2, "name": "TENELIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108144", "mechanisms": ["Tumor necrosis factor receptor superfamily member 5 partial agonist"], "genes": ["CD40"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 4, "name": "YTTRIUM Y 90 IBRITUMOMAB TIUXETAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108667", "mechanisms": ["B-lymphocyte antigen CD20 binding agent"], "genes": ["MS4A1"], "type": "Antibody", "diseases": []}], "heat": 0.8759611362816667, "nodes": [{"assoc": 0.743932157773, "id": "ENSG00000101017", "label": "CD40"}, {"assoc": 1.0, "id": "ENSG00000156738", "label": "MS4A1"}, {"assoc": 0.883951251072, "id": "ENSG00000204287", "label": "HLA-DRA"}], "size": 3}, {"diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "CROHN'S DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "MULTIPLE MYELOMA", "RHEUMATOID ARTHRITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "IMMUNE SYSTEM DISEASE", "ULCERATIVE COLITIS", "CELIAC DISEASE", "HIV INFECTION", "MELANOMA", "RENAL CELL CARCINOMA"], "links": [{"source": "ENSG00000115232", "target": "ENSG00000139626"}, {"source": "ENSG00000115232", "target": "ENSG00000150093"}, {"source": "ENSG00000139626", "target": "ENSG00000150093"}], "drugs": [{"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}], "max_phase": 4, "name": "NATALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201607", "mechanisms": ["Integrin alpha-4/beta-1 inhibitor", "Integrin alpha-4/beta-7 inhibitor"], "genes": ["ITGA4", "ITGB7", "ITGB1"], "type": "Antibody", "diseases": ["MULTIPLE SCLEROSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "CROHN'S DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "MULTIPLE MYELOMA", "RHEUMATOID ARTHRITIS", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "IMMUNE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "CROHN'S DISEASE", "stage": 4}, {"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "CELIAC DISEASE", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "VEDOLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743087", "mechanisms": ["Integrin alpha-4/beta-7 inhibitor"], "genes": ["ITGA4", "ITGB7"], "type": "Antibody", "diseases": ["CROHN'S DISEASE", "ULCERATIVE COLITIS", "IMMUNE SYSTEM DISEASE", "CELIAC DISEASE", "HIV INFECTION"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 3}, {"efo_term": "CROHN'S DISEASE", "stage": 3}], "max_phase": 3, "name": "ETROLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743015", "mechanisms": ["Integrin beta-7 antagonist"], "genes": ["ITGB7"], "type": "Antibody", "diseases": ["ULCERATIVE COLITIS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}], "max_phase": 3, "name": "VOLOCIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108061", "mechanisms": ["Integrin alpha-5/beta-1 antagonist"], "genes": ["ITGB1"], "type": "Antibody", "diseases": ["MELANOMA", "RENAL CELL CARCINOMA"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "FIRATEGRAST", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104967", "mechanisms": ["Integrin alpha-4/beta-1 antagonist", "Integrin alpha-4/beta-7 antagonist"], "genes": ["ITGA4", "ITGB7", "ITGB1"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 1}], "max_phase": 2, "name": "INTETUMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743032", "mechanisms": ["Integrin alpha-V/beta-1 antagonist"], "genes": ["ITGB1"], "type": "Antibody", "diseases": ["MELANOMA"]}, {"indications": [], "max_phase": 2, "name": "DI17E6", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109621", "mechanisms": ["Integrin alpha-V/beta-1 inhibitor"], "genes": ["ITGB1"], "type": "Antibody", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000115232", "label": "ITGA4"}, {"assoc": 1.0, "id": "ENSG00000139626", "label": "ITGB7"}, {"assoc": 1.0, "id": "ENSG00000150093", "label": "ITGB1"}], "size": 3}, {"diseases": ["ACNE", "PERIODONTITIS", "BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"], "links": [{"source": "ENSG00000118113", "target": "ENSG00000137673"}, {"source": "ENSG00000118113", "target": "ENSG00000196611"}, {"source": "ENSG00000137673", "target": "ENSG00000196611"}], "drugs": [{"indications": [{"efo_term": "PERIODONTITIS", "stage": 3}, {"efo_term": "URETHRITIS", "stage": 3}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PLEURAL EFFUSION", "stage": 3}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 3}, {"efo_term": "BLEPHARITIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "ABDOMINAL AORTIC ANEURYSM", "stage": 2}, {"efo_term": "MARFAN SYNDROME", "stage": 2}, {"efo_term": "PRIMARY SYSTEMIC AMYLOIDOSIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "SEPTICEMIC PLAGUE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 2}], "max_phase": 4, "name": "DOXYCYCLINE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200699", "mechanisms": ["Matrix metalloproteinase 8 inhibitor", "Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP8", "MMP7", "MMP1"], "type": "Small molecule", "diseases": ["BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "PERIODONTITIS", "ACNE", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "PERIODONTITIS", "stage": 3}], "max_phase": 4, "name": "DOXYCYCLINE HYCLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200567", "mechanisms": ["Matrix metalloproteinase 8 inhibitor", "Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP8", "MMP7", "MMP1"], "type": "Small molecule", "diseases": ["ACNE", "PERIODONTITIS"]}, {"indications": [], "max_phase": 4, "name": "DOXYCYCLINE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364574", "mechanisms": ["Matrix metalloproteinase 8 inhibitor", "Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP8", "MMP7", "MMP1"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000118113", "label": "MMP8"}, {"assoc": 1.0, "id": "ENSG00000137673", "label": "MMP7"}, {"assoc": 1.0, "id": "ENSG00000196611", "label": "MMP1"}], "size": 3}], "auto_delta": "0.00265875"}